Abstract
Background
Active mind‐body movement therapies (AMBMTs), including but not limited to yoga, tai chi, and qigong, have been applied as exercise modalities for people with chronic obstructive pulmonary disease (COPD). AMBMT strategies have been found to be more effective than usual care; however, whether AMBMT is inferior, equivalent, or superior to pulmonary rehabilitation (PR) in people with COPD remains to be determined.
Objectives
To assess the effects of AMBMTs compared with, or in addition to, PR in the management of COPD.
Search methods
We searched the Cochrane Airways Group Specialised Register of trials and major Chinese databases, as well as trial registries from inception to July 2017. In addition, we searched references of primary studies and review articles. We updated this search in July 2018 but have not yet incorporated these results.
Selection criteria
We included (1) randomised controlled trials (RCTs) comparing AMBMT (i.e. controlled breathing and/or focused meditation/attention interventions for which patients must actively move their joints and muscles for at least four weeks with no minimum intervention frequency) versus PR (any inpatient or outpatient, community‐based or home‐based rehabilitation programme lasting at least four weeks, with no minimum intervention frequency, that included conventional exercise training with or without education or psychological support) and (2) RCTs comparing AMBMT + PR versus PR alone in people with COPD. Two independent review authors screened and selected studies for inclusion.
Data collection and analysis
Two review authors independently selected trials for inclusion, extracted outcome data, and assessed risk of bias. We contacted study authors if necessary to ask them to provide missing data. We calculated mean differences (MDs) using a random‐effects model.
Main results
We included in the meta‐analysis 10 studies with 762 participants across one or more comparisons. The sample size of included studies ranged from 11 to 206 participants. Nine out of 10 studies involving all levels of COPD severity were conducted in China with adults from 55 to 88 years of age, a higher proportion of whom were male (78%). Nine out of 10 studies provided tai chi and/or qigong programmes as AMBMT, and one study provided yoga. Overall, the term 'PR' has been uncritically applied in the vast majority of studies, which limits comparison of AMBMT and PR. For example, eight out of 10 studies considered walking training as equal to PR and used this as conventional exercise training within PR. Overall study quality for main comparisons was moderate to very low mainly owing to imprecision, indirectness (exercise component inconsistent with recommendations), and risk of bias issues. The primary outcomes for our review were quality of life, dyspnoea, and serious adverse events.
When researchers compared AMBMT versus PR alone (mainly unstructured walking training), statistically significant improvements in disease‐specific quality of life (QoL) (St. George's Respiratory Questionnaire (SGRQ) total score) favoured AMBMT: mean difference (MD) ‐5.83, 95% confidence interval (CI) ‐8.75 to ‐2.92; three trials; 249 participants; low‐quality evidence. The common effect size, but not the 95% CI around the pooled treatment effect, exceeded the minimal clinically important difference (MCID) of minus four. The COPD Assessment Test (CAT) also revealed statistically significant improvements favouring AMBMT over PR, with scores exceeding the MCID of three, with an MD of 6.58 units (95% CI ‐9.16 to – 4.00 units; one trial; 74 participants; low‐quality evidence). Results show no between‐group differences with regard to dyspnoea measured by the modified Medical Research Council Scale (MD 0.00 units, 95% CI ‐0.37 to 0.37; two trials; 127 participants; low‐quality evidence), the Borg Scale (MD 0.44 units, 95% CI ‐0.88 to 0.00; one trial; 139 participants; low‐quality evidence), or the Chronic Respiratory Questionnaire (CRQ) Dyspnoea Scale (MD ‐0.21, 95% CI ‐2.81 to 2.38; one trial; 11 participants; low‐quality evidence). Comparisons of AMBMT versus PR alone did not include assessments of generic quality of life, adverse events, limb muscle function, exacerbations, or adherence.
Comparisons of AMBMT added to PR versus PR alone (mainly unstructured walking training) revealed significant improvements in generic QoL as measured by Short Form (SF)‐36 for both the SF‐36 general health summary score (MD 5.42, 95% CI 3.82 to 7.02; one trial; 80 participants; very low‐quality evidence) and the SF‐36 mental health summary score (MD 3.29, 95% CI 1.45 to 4.95; one trial; 80 participants; very low‐quality evidence). With regard to disease‐specific QoL, investigators noted no significant improvement with addition of AMBMT to PR versus PR alone (SGRQ total score: MD ‐2.57, 95% CI ‐7.76 to 2.62 units; one trial; 192 participants; moderate‐quality evidence; CRQ Dyspnoea Scale score: MD 0.04, 95% CI ‐2.18 to 2.26 units; one trial; 80 participants; very low‐quality evidence). Comparisons of AMBMT + PR versus PR alone did not include assessments of dyspnoea, adverse events, limb muscle function, exacerbations, or adherence.
Authors' conclusions
Given the quality of available evidence, the effects of AMBMT versus PR or of AMBMT added to PR versus PR alone in people with stable COPD remain inconclusive. Evidence of low quality suggests better disease‐specific QoL with AMBMT versus PR in people with stable COPD, and evidence of very low quality suggests no differences in dyspnoea between AMBMT and PR. Evidence of moderate quality shows that AMBMT added to PR does not result in improved disease‐specific QoL, and evidence of very low quality suggests that AMBMT added to PR may lead to better generic QoL versus PR alone. Future studies with adequate descriptions of conventional exercise training (i.e. information on duration, intensity, and progression) delivered by trained professionals with a comprehensive understanding of respiratory physiology, exercise science, and the pathology of COPD are needed before definitive conclusions can be drawn regarding treatment outcomes with AMBMT versus PR or AMBMT added to PR versus PR alone for patients with COPD.
Plain language summary
Active mind‐body movement therapies for chronic obstructive pulmonary disease
Background
Chronic obstructive pulmonary disease (COPD) is a major cause of ill health and is currently the fourth leading cause of death worldwide. COPD describes a chronic lung condition in which shortness of breath, tiredness, and exercise intolerance are typical symptoms. Active mind‐body movement therapies (AMBMTs) consist of mind‐body therapies such as controlled breathing and/or focused meditation/attention interventions whereby participants must actively move their joints and muscles (e.g. yoga, tai chi, qigong). Although different forms of AMBMT may differ in origin, they usually share similar principles: movement/posture, controlled breathing, and focused attention/meditation. AMBMT strategies applied to people with COPD have been found to be more effective than usual care. However the effect of AMBMT as an adjunct to or in direct comparison with pulmonary rehabilitation (PR), the cornerstone of COPD management, remains to be determined; this is the objective of the current review.
Study characteristics
We included 10 studies involving 762 participants who were randomly assigned to receive AMBMT alone or in combination with PR or PR alone (mainly unstructured walking training). The quality of included studies was generally poor.
Key results
Given the quality of available evidence, effects of AMBMT in comparison with PR or of AMBMT added to PR in comparison with PR alone remain inconclusive. One key reason for this is that PR programmes used as comparators had major design flaws, for example, the term 'PR' was uncritically used in the vast majority of studies, and PR was often considered equal to unstructured walking training. This, together with the poor quality of evidence, limits our confidence in the observed effects. Available evidence suggests that when AMBMT was compared to PR alone, larger improvements in disease‐specific quality of life were observed with AMBMT, although AMBMT was not superior to PR with regard to dyspnoea (breathlessness). AMBMT added to PR resulted in large improvement in generic quality of life when compared with PR alone, although the addition of AMBMT to PR did not lead to further improvements in disease‐specific quality of life. However, before definitive conclusions can be drawn, future research studies comparing AMBMT to PR are needed, and these should follow current PR guidelines for designing comparator interventions, preferably delivered by properly trained professionals with a comprehensive understanding of respiratory physiology, exercise science, and the pathology of COPD.
Summary of findings
Background
Description of the condition
Chronic obstructive pulmonary disease (COPD) is characterised by chronic airflow limitation. It is considered a systemic and multi‐component disease with cough, sputum production, and chronic, progressive dyspnoea (breathlessness) and exercise intolerance as typical symptoms (Butcher 2012; GOLD 2018). The number of people living with COPD is steadily increasing, and COPD is a major cause of morbidity and mortality; it is projected to become the third leading cause of death worldwide in 2030 (WHO 2013). The international prevalence of Global Initiative on Obstructive Lung Disease (GOLD) stage 2 and higher COPD has been reported to be 10.1% and is believed to be increasing, which can be explained to some extent by continued exposure to risk factors in combination with ageing of the world's population (Buist 2007;GOLD 2018).
COPD is usually caused by long‐term exposure to lung irritants that cause damage to the lungs and airways. The most prevalent irritant known to cause COPD is cigarette smoke, but others such as second‐hand smoke, air pollution, chemicals, and dust particles from workplace environments have been involved.
Individuals who present with symptoms of dyspnoea, chronic cough, and/or sputum production should be considered for a diagnosis of COPD. To diagnose the disease, a spirometry is mandatory to confirm the presence of airflow limitation. According to GOLD, a ratio of forced expiratory volume in one second (FEV₁)/forced vital capacity (FVC) < 0.70 indicates airflow limitation. If consistent clinical features are noted, persistent airflow limitation confirms the diagnosis of COPD. COPD assessment should determine (1) the severity of airflow limitation, (2) the impact of the disease on the patient's health status, and (3) the risk of future exacerbations, to guide therapy. Coexistent diseases should be actively looked for and treated appropriately if present (GOLD 2018).
Exercise intolerance is considered one of the key features of COPD (Butcher 2012; Houchen 2009). Ventilatory limitation, hyperinflation, gas exchange abnormalities, and cardiac and limb muscle dysfunction, alone or in combination, have been proposed as factors contributing to exercise limitation in COPD (Spruit 2013). As the disease progresses, patients experience recurrent exacerbations, increased dyspnoea, and more frequent hospital visits, collectively leading to poor quality of life (GOLD 2018; Miravitlles 2007).
Management of COPD includes identification and reduction of exposure to risk factors, as well as pharmacological and non‐pharmacological treatments. With regard to the latter, pulmonary rehabilitation is recognised as a core component of COPD management (Vogelmeier 2017).
Description of the intervention
Active mind‐body movement therapies (AMBMTs)
Mind‐body practices, as defined by the National Center for Complementary and Integrative Health, from the National Institutes of Health, are classified amongst the most popular complementary health approaches used by adults in the general population (Harris 2012). These practices focus on the interaction between mind and body by using internal awareness, anatomical alignment, and deep breathing to improve individual wellness. Mind‐body practices can be categorised into three different subgroups (adapted from Lee 2014). First, the intervention may be motionless (e.g. meditation, hypnosis, relaxation therapy). Second, the intervention may involve passive movement. In this case, motion is transmitted to parts of the body by an external force (e.g. massage therapy, spinal manipulation). Third, the intervention may include active mind‐body movement therapies (AMBMTs), whereby participants must move their joints and muscles (e.g. yoga, tai chi, qigong, Pilates). Although different forms of AMBMT may differ in origin, they usually share similar principles: movement/posture, controlled breathing, and focused attention/meditation (Table 3). The intensity of these interventions has rarely been reported. However, studies have shown that some AMBMTs are exercises of light to moderate intensity (Hagins 2007; Lan 2008). Participants may adjust the difficulty of such exercises to their own desired level of conditioning. A fundamental component of AMBMTs, which sets them apart from conventional exercise training, is mindful awareness. Participants learn to recognise tension or strain in different areas of the body, or aspects of breathing that feel arduous or effortless, while performing a posture or movement. This mindful awareness may complement and improve other components such as posture and relaxation. Preliminary evidence suggests that tai chi and qigong may improve exercise capacity, dyspnoea, quality of life, and lung function compared to conventional exercise or usual care in patients with COPD (Ng 2014a; Yan 2013).
1. Description of different AMBMTs.
| Intervention | Description | Reference |
| Tai chi | Originally developed as a martial art in China around the 16th century (origins unclear), training emphasises focusing attention, co‐ordinating breathing with movements, and aligning proper posture in a rhythmical sequence and at a constant rate | Ng 2014a |
| Qigong | Originating from Traditional Chinese Medicine (TCM) and refined for over 5000 years, qigong exercises consist of postures, breathing techniques, and meditation, all designed to enhance Qi function (concept of force or energy in TCM) through attainment of deeply focused and relaxed states | Jahnke 2010 |
| Yoga | Practised in India as early as 3000 before common era and can be simplified as a combination of postures (Asanas), breathing techniques (Pranayamas), and sustained concentration (Dhyana) | Taneja 2014 |
| Pilates | Created in the United States in the early 20th century and matured as a combination of structured physical exercises focusing on concentration, control, centreing, flowing movement, precision, and breathing | Bullo 2015 |
TCM: Traditional Chinese Medicine.
Pulmonary rehabilitation (PR)
Pulmonary rehabilitation (PR) is defined as a comprehensive intervention based on a thorough patient assessment followed by patient‐tailored therapies, which include, but are not limited to, exercise training, education, and behaviour change. Pulmonary rehabilitation is designed to improve the physical and psychological condition of people with chronic respiratory disease and to promote long‐term adherence to health‐enhancing behaviours (Spruit 2013). For the purposes of this review, we adopted a broad definition of PR to encompass programmes that include exercise training lasting at least four weeks, irrespective of the delivery of education or psychological support ‐ a definition that was used in the most recent Cochrane review of PR in COPD (McCarthy 2015). Pulmonary rehabilitation relieves dyspnoea and improves quality of life and exercise capacity for people with COPD. A recent Cochrane review found these improvements to be moderately large and clinically significant (McCarthy 2015). Rehabilitation serves as an important component in the management of COPD.
How the intervention might work
Mechanisms potentially involved in the effects observed with AMBMT include cardiorespiratory and skeletal muscle conditioning, mindfulness and self‐awareness, enhanced concentration, improved breathing control, overall mood and stress management, collective improvement in outcomes of quality of life, exercise capacity, balance, and symptoms in patients with COPD. The combination of self‐controlled posture, movement, breathing, and mindfulness is thought to activate naturally occurring mechanisms of self‐repair and health recovery (Jahnke 2010). It has been hypothesised that mindfulness training, that is, increasing awareness of breathing and posture, would allow patients with COPD to better anticipate and prepare themselves for management of aggravating symptoms of dyspnoea and anxiety (Yeh 2014). Breathing techniques taught during AMBMT, such as deep breathing, diaphragmatic breathing, and pursed‐lip breathing, may increase tidal volume and decrease respiratory rate while improving gas exchange and air trapping (Cahalin 2002). Furthermore, these techniques may improve both inspiratory and expiratory muscle performance, improving, in turn, the capacity of the chest cavity to create negative and positive pressures during the respiration process (Santaella 2011). Controlled breathing has been shown to reduce breathlessness and fatigue while improving disease‐specific quality of life in patients with COPD (Borge 2014). Additionally, AMBMT may have an adjuvant effect when incorporated into conventional PR programmes. Indeed, it has been reported that integrating tai chi into conventional PR led to favourable improvements in exercise capacity and health status when compared with use of conventional PR alone (Ng 2014a).
Why it is important to do this review
Despite high‐grade evidence showing the effectiveness of PR in COPD, access to conventional programmes has been estimated to be less than 2% worldwide (Desveaux 2015). AMBMT could address part of the accessibility issue and may be suitable for better long‐term adherence, especially for people who dislike structured conventional fitness programmes. Across the globe, complementary health approaches are increasingly popular. In the United States, it has been reported that approximately 38% of adults were using some form of complementary health approach in 2007, and that use of this approach is significantly increasing. Corresponding numbers for adults were 26%, 52%, and 76%, in UK, Australia, and Singapore, respectively (Harris 2012). Therefore, use of AMBMT as an alternative to conventional exercise training and PR is likely to rise in parallel with increased prevalence of COPD. In this regard, a systematic review of the effectiveness of AMBMT and its comparison with conventional PR presents a topic of interest for both patients and healthcare providers.
Objectives
To assess the effects of active mind‐body movement therapies (AMBMTs) compared with, or in addition to, pulmonary rehabilitation (PR) in the management of chronic obstructive pulmonary disease (COPD).
Methods
Criteria for considering studies for this review
Types of studies
We included published and unpublished randomised controlled trials (RCTs) comparing AMBMT versus PR and those comparing AMBMT in addition to PR versus PR alone for managing COPD.
Types of participants
We included RCTs in which participants:
had a clinical diagnosis of COPD as defined by GOLD guidelines (GOLD 2018);
had a best recorded FEV₁/FVC ratio < 0.7; and
were ≥ 18 years of age.
We accepted studies with mixed populations, but we included only data reported for participants with COPD.
Types of interventions
The review involved two types of comparisons.
Comparisons to test the hypothesis that AMBMT is inferior, equivalent, or superior to PR: AMBMT versus PR.
Comparisons to examine the treatment effects of AMBMT on top of PR versus PR alone: AMBMT + PR versus PR.
AMBMTs
AMBMTs are defined as mind‐body therapies (i.e. controlled breathing and/or focused meditation/attention interventions whereby patients must actively move their joints and muscles). We included yoga, tai chi, qigong, and Pilates. We also included a category described as 'others', in case we discovered new or differently named interventions that satisfy the AMBMT definition. For instance, we included in this category some traditional Chinese exercises closely related to tai chi and qigong characterised by the same principles espoused by AMBMT (e.g. baguazhang, xing yi quan). We excluded mind and body therapies limited to breathing and/or meditation without active movements/postures (e.g. Pranayama yoga). We included studies that reported on programmes of at least four weeks' duration with no minimum intervention frequency.
PR
We used the following operational definition of PR for the purposes of this review: any inpatient, outpatient, community‐based, or home‐based rehabilitation programme of at least four weeks' duration with no minimum intervention frequency that included exercise training with or without any form of education and/or psychological support delivered to patients with exercise limitations attributable to COPD (McCarthy 2015). Exercise training is described as any continuous endurance or interval exercise or upper limb or lower limb training in the form of walking (ground‐based or on a treadmill) and cycling with or without resistance/strength training, flexibility training, or inspiratory muscle training (Garvey 2016; Spruit 2013).
Types of outcome measures
Primary outcomes
Disease‐specific quality of life (all validated tools were considered, e.g. Chronic Respiratory Disease Questionnaire (CRQ), St. George's Respiratory Questionnaire (SGRQ), COPD Assessment Test (CAT))
Generic health‐related quality of life (e.g. Short Form (SF)‐36)
Dyspnoea (all validated tools were considered, e.g. Medical Research Council (MRC) Scale, BORG Scale, Transitional Dyspnoea Index (TDI), Dyspnoea domain of the CRQ))
Serious adverse events (all types)
Secondary outcomes
-
Exercise capacity
Maximal exercise performance: incremental cycle ergometry (ICE) or incremental shuttle walk test (ISWT)
Functional exercise capacity: 6‐minute walk test (6MWT/6MWD), endurance shuttle walk test (ESWT), endurance cycle test
-
Pulmonary function
FEV₁ and percentage of predicted values (FEV₁ predicted, %)
FVC
FEV₁/FVC ratio
-
Limb muscle function (strength, endurance, and fatigue)
Muscle strength: changes in maximal muscle force (e.g. maximal voluntary contractions (MVCs))
Muscle endurance: changes in muscle force over time (exercise tolerance) (e.g. time to failure when maximal or submaximal contractions were performed)
Muscle fatigue: changes in muscle force over time through a fatigue index, work slope, or similar tool (e.g. measuring twitch muscle force via potentiated or unpotentiated magnetic stimulation)
Exacerbations (an exacerbation of COPD was defined as a new respiratory event or complication prompting patient evaluation and initiation of additional treatment regimens including antibiotics and/or systemic steroids)
Adherence (ratio between participants analysed and participants who received intervention)
Search methods for identification of studies
Electronic searches
We contacted the Information Specialist to request a search in the Cochrane Airways Group Register of Trials (CAGR) that includes trials from the following databases: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), the Complementary Medicine Database (AMED), and PsycINFO (see Appendix 1 for more details). We have provided the search strategy for the Airways Register in Appendix 2. Furthermore, we searched the following major electronic Chinese databases (Cohen 2015; Xia 2008): China National Knowledge Infrastructure (CNKI), WANGFAN, VIP, and SinoMed (Chinese Biomedical Literature Database, Chinese Medical Science Literature Database, and Beijing Union Medical Doctor and Master Thesis Database). We also searched the Indian Biomedical Journals Database (IndMED) using the same search terms found in Appendix 2. In Appendix 3, we have presented the search terms that we used for non‐CAGR databases.
We searched for ongoing studies in the following databases: the World Health Organization International Clinical Trials Registry Platform (ICTRP), the Chinese Clinical Trial Registry (ChiCTR), the International Standard Randomised Controlled Trial Number (ISRCTN) database, and the National Institutes of Health Clinical Trials Database (ClinicalTrials.gov). We applied no language restrictions in selecting publications, and a qualified translator assisted when required. We searched all sources from their inception up to 5 July 2017. We performed a further search in July 2018. We have added those results to Studies awaiting classification and will incorporate them into the review at the next update.
Searching other resources
We checked the reference lists of all included studies and review articles for additional related references. We searched conference proceedings relevant to this review, and, if required, we contacted the authors of identified trials to ask about unpublished studies or to request missing information.
Data collection and analysis
Selection of studies
Two review authors (LMcG and AN) independently screened titles and abstracts identified by the search and coded them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We retrieved full‐text study reports/publications, and two review authors (LMcG and AN) independently screened the full‐text studies, identified studies for inclusion, and identified and recorded reasons for exclusion of ineligible studies. We resolved disagreements through discussion, or, if required, we consulted a third review author (YL). We identified and excluded duplicates and collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (Moher 2009), as well as an Excluded studies table.
Data extraction and management
Two review authors (LMcG and AN) independently duplicated data extraction to minimise errors and reduce potential biases. We documented extracted data on a data extraction form and included demographics of participants, a full description of the interventions used (type, duration, setting), and outcome measures (quality of life questionnaires, dyspnoea levels, adverse events, exercise capacity, pulmonary function, muscle function, exacerbations, and adherence). We then entered the extracted data into RevMan software for further analysis.
Assessment of risk of bias in included studies
We evaluated risk of bias by using the Cochrane tool for assessing risk of bias as defined in the Cochrane Handbook for Systematic Reviews of Interventions. Two review authors (LMcG and AN) assessed risk of bias independently for each study and resolved disagreements by discussion with a third review author (YL). We graded risk of bias as high, low, or unclear for each study, and we created plots to report risk of bias for (1) random sequence generation; (2) allocation concealment; (3) blinding of participants and personnel (performance bias); (4) blinding of outcome assessments (detection bias); (5) incomplete outcome data; (6) selective outcome reporting; (7) other sources of bias; and (8) overall risk of bias, as described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).
Assesment of bias in conducting the systematic review
We conducted the review according to this published protocol and reported any deviations from it in the Differences between protocol and review section of the systematic review.
Measures of treatment effect
Continuous data
For continuous data, we used mean differences (MDs) to evaluate the overall effect size for different outcomes when study measurements were based on the same scale. We reported results as means with 95% confidence intervals (CIs).
Dichotomous data
For dichotomous measures, we planned to express data as odd ratios (ORs) with 95% CIs. For trials for which standard errors cannot be calculated (i.e. no events are reported in one intervention group), we planned to use the method described in the Cochrane Handbook for Systematic Reviews of Interventions, which consists of adding 0.5 to each cell of calculation tables when necessary (automatically added in RevMan).
Unit of analysis issues
The unit of analysis was the participant. We included data from parallel‐group studies for meta‐analysis. For studies involving repeated measures, we used single time points near the most frequently encountered time frame for analysis. For multi‐armed trials, we selected the pair of interventions of interest and excluded the others. For cluster‐randomised trials, we planned adjustments to the sample size for each intervention based on the method described in the Cochrane Handbook for Systematic Reviews of Interventions.
Dealing with missing data
We contacted study authors of the original investigations to request information on missing numerical data or information regarding randomisation, blinding, or allocation concealment. When the standard deviation (SD) of the change was missing from a study, and it was not possible to obtain the result from study authors, we used the post‐intervention value for the SD of the study. We considered studies with attrition greater than 20% to be at high risk of bias (Schulz 2002).
Assessment of heterogeneity
We determined heterogeneity in each meta‐analysis by using T², I², and Chi² statistics. We interpreted heterogeneity by following guidelines provided in the Cochrane Handbook for Systematic Reviews of Interventions. We interpreted a P value less than 0.1 as statistically significant for heterogeneity, and we interpreted further analysis of I² as follows.
0% to 40%: might not be important.
30% to 60%: may represent moderate heterogeneity.
50% to 90%: may represent substantial heterogeneity.
75% to 100%: shows considerable heterogeneity.
Assessment of reporting biases
If we included 10 or more studies in a meta‐analysis, we planned to use funnel plots to evaluate the presence of publication bias. However, as all meta‐analyses included fewer than 10 studies, we created no funnel plots.
Data synthesis
We independently reviewed and presented two comparisons.
AMBMT versus PR.
AMBMT + PR versus PR.
We conducted statistical analysis using Review Manager software (RevMan 2014), and we used the random‐effects model to obtain the overall summary of average treatment effects across studies. We included a summary of results for different outcomes: forest plots, effect sizes with 95% CIs, and estimates of T², I², and P values.
'Summary of findings' table
In the 'Summary of findings' table, we reported on dyspnoea, quality of life, and adverse events.
We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to studies that contributed data to the meta‐analyses for prespecified outcomes. We applied methods and recommendations described in Section 8.5 and Chapter 12 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), using GRADEpro GDT software. We justified all decisions to downgrade or upgrade the quality of studies by using footnotes, and we provided comments to aid the reader's understanding of the review when necessary.
Subgroup analysis and investigation of heterogeneity
We performed subgroup analyses, if necessary, to determine possible sources of heterogeneity between studies. We considered the following subgroups.
Types of AMBMT.
Intensities of different interventions (duration, times per week).
COPD severity according to GOLD standards for grading of airflow limitation severity.
Sensitivity analysis
No sensitivity analysis was needed, so we performed none. We would have performed a sensitivity analysis if needed to examine the effects of study quality by excluding studies with inadequate randomisation and/or allocation concealment.
Results
Description of studies
See Characteristics of included studies and Characteristics of excluded studies for complete details of included and excluded studies.
Results of the search
We have presented a summary of the search results in Figure 1. We identified a total of 679 records using search methods, and we retained 366 after removing duplicates. After screening of the unique identified records, we excluded 300 upon review of titles and abstracts, and we assessed 66 full‐text articles for eligibility. From these full‐text articles, we included 10 studies (leading to 18 publications) in the meta‐analysis. From an updated search in July 2018, we added eight studies to Studies awaiting classification and will consider them for inclusion in the update of this review. Agreement between the two review authors (LMcG and AN) was excellent, as reflected by a calculated kappa value of 0.90 obtained before data were extracted from the included studies.
1.

Study flow diagram.
Included studies
We have presented study details in the Characteristics of included studies section. Of 10 RCTs, six studies were published in English (Chan 2010; Liu 2012; Ng 2011; Ng 2014; Niu 2014; Papp 2017), and four were published in Chinese (Du 2013; Yang 2009; Zhu 2010; Zhu 2011).
Design
Eight studies compared AMBMT versus PR in COPD (Chan 2010; Du 2013; Liu 2012; Niu 2014; Papp 2017; Yang 2009; Zhu 2010; Zhu 2011). Six of these eight studies were multi‐arm RCTs comparing three groups: AMBMT, PR, and control versus no exercise intervention (Chan 2010; Du 2013; Liu 2012; Yang 2009; Zhu 2010; Zhu 2011). Two studies investigated the adjunct effects of AMBMT in PR on COPD (Ng 2011; Ng 2014). Six studies had a programme duration of 12 weeks (Chan 2010; Du 2013; Papp 2017; Yang 2009; Zhu 2010; Zhu 2011), and four studies collected outcome measures at six months post intervention (Liu 2012; Ng 2011; Ng 2014; Niu 2014). Session administration varied from daily to twice a week, and from 30 minutes to 80 minutes per session.
Sample size
The sample size of included studies varied from 11 to 206 participants. When participants from groups not of interest for this review were removed (i.e. groups with no exercise intervention), the total number of included participants was 762.
Setting
Nine studies were conducted in China; of these, three were reported from Hong Kong (Chan 2010; Ng 2011; Ng 2014), and the others were reported from different provinces of mainland China (Du 2013; Liu 2012; Niu 2014; Yang 2009; Zhu 2010; Zhu 2011). Chinese studies were carried out in outpatient clinics of hospitals. One study was conducted in Stockholm, Sweden, and also included an outpatient population (Papp 2017).
Participants
The age of participants varied from 55 to 88 years, and studies included a higher proportion of males (mean percentage of men was 78%, ranging from 59% to 91%). Two studies recruited only patients with mild to moderate COPD (Liu 2012; Du 2013), and others included patients with all types of severities. Papp 2017 included a mixed population of patients with the diagnosis of asthma or COPD; however, we used only data from COPD participants in this review.
Interventions
For the first comparison (AMBMT vs PR), the AMBMT involved qigong (Wuqinxi, Liuzijue, Baduanjin, and routines selected from China's national standardised protocols) in four studies (Liu 2012; Yang 2009; Zhu 2010; Zhu 2011), tai chi (24‐Yang style routine and selected routines) in two studies (Du 2013; Niu 2014), tai chi with qigong (a modified 13‐form of TQG) in one study (Chan 2010), and yoga (hatha yoga) in one other study (Papp 2017). Training programmes for PR interventions consisted of breathing techniques with self‐paced walking in four studies (Chan 2010; Du 2013; Niu 2014; Yang 2009), walking at a pace of 80 to 120 steps/min in two studies (Zhu 2010; Zhu 2011), walking and cycling in one study (Liu 2012), and aerobic exercise with full body resistance exercises in another study (Papp 2017).
For the second comparison (AMBMT + PR vs PR), one study involved qigong (Baduanjin) (Ng 2011), and the other Sun‐style tai chi, as AMBMT (Ng 2014). PR interventions consisted of self‐paced walking with co‐ordinated breathing in one study (Ng 2011). The other study provided a set of warm‐up exercises, aerobic activities (treadmill and lower limb ergometry), resistance training (Thera‐Band) exercises, and a relaxation period (Ng 2014).
Excluded studies
We excluded 34 studies after reading the full‐text articles. Reasons for exclusion included lack of an eligible control group (30 studies), participants with no COPD diagnosis (one study), inclusion of no proper AMBMT (one study), and non‐RCT study design (two studies). We have provided additional information in the Characteristics of excluded studies table.
Studies awaiting classification
Through the most recent search, we retrieved eight studies for potential inclusion in the upcoming update of this review (see Studies awaiting classification). We could not obtain information and data for two studies (Kaminsky 2011;Price 2006).
Ongoing studies
We found four ongoing studies that were eligible for inclusion in this review (see Characteristics of ongoing studies): two studies included tai chi (NCT01998724; NCT02370654), and two others included some form of qigong (ChiCTR‐IOR‐17012437; ChiCTR‐TRC‐14004404).
Risk of bias in included studies
We have provided a summary of the general risk of bias across all studies in Figure 2 and Figure 3.
2.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
3.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Allocation
All studies described appropriate randomisation procedures; we therefore judged them to be at low risk of bias. Two studies provided a proper description of allocation concealment (Ng 2014; Papp 2017), and we considered them at low risk of bias. We considered one study to be at high risk of selection bias for inadequate allocation (Ng 2011). The remaining studies provided insufficient information to permit judgement of low or high risk.
Blinding
Blinding of participants was mostly implausible for AMBMT and PR interventions; therefore, we considered all studies to be at high risk for performance bias. Six studies provided QoL and dyspnoea scores assessed by participants, rendering detection bias high risk because participants were not blinded to the treatment received (Chan 2010; Du 2013; Liu 2012; Ng 2011; Ng 2014; Papp 2017). We considered Niu 2014 to be at low risk because study authors provided sufficient information regarding blinding of assessors and did not include any self‐reporting outcomes. The remaining studies provided insufficient information to permit judgement of low or high risk.
Incomplete outcome data
Of five studies reporting an intention‐to‐treat analysis (Chan 2010; Liu 2012; Ng 2011; Ng 2014; Papp 2017), two reported an attrition rate less than 20% (Liu 2012; Papp 2017); we considered them at be at low risk and the remaining three studies to be at high risk. The other studies did not report sufficient information to permit judgement of low or high risk.
Selective reporting
One study showed no differences between registration and outcomes reported in the published results articles (Ng 2014). However, we found no records in clinical trials registers for the other studies, to permit judgement of low or high risk.
Other potential sources of bias
It is unclear whether conducting studies only in China on a Chinese population is a limitation to the external validity of trial results. It is also unclear whether differences between interventions, time points, and disease severity could introduce any other potential sources of bias. Chan 2010 reported an unbalanced baseline exacerbation rate between AMBMT and PR intervention groups, and this could be a potential source of bias.
Effects of interventions
Summary of findings for the main comparison. Summary of findings for AMBMT vs PR.
| Active mind‐body movement therapies (AMBMTs) vs pulmonary rehabilitation (PR) for chronic obstructive pulmonary disease | ||||
|
Patient or population: patients with chronic obstructive pulmonary disease Settings: any setting Intervention: AMBMT Control: PR | ||||
| Outcomes | Illustrative comparative effects* (95% CI) | No. of participants (studies) | Quality of the evidence (GRADE) | |
| Response on control | Treatment effect | |||
| PR | AMBMT vs PR | |||
|
QoL ‐ Change in SGRQ total score Scale 0 to 100. Lower is better and 4 units is a clinically important difference |
Mean change = ‐1.92 units | Mean change in SGRQ total score in the AMBMT group was 5.83 units lower (95% CI 8.75 to 2.92 to lower) |
249 (3 RCTs) | ⊕⊕⊝⊝ lowa |
|
QoL ‐ Change in CAT score Scale 0 to 40. Lower is better and 3 units is a clinically important difference |
Mean change = 2.74 units | Mean change in CAT score in the AMBMT group was 6.58 units lower (95% CI 9.16 to 4.00 lower) |
74 (1 RCT) | ⊕⊕⊝⊝ lowb |
|
Dyspnoea ‐ change in CRQ Dyspnoea CRQ Dyspnoea. Scale 1 to 7. Higher is better and 0.5 unit is a clinically important difference |
Mean change = 0.24 units | Mean change in CRQ score in the AMBMT group was 0.21 units lower (95% CI 2.81 lower to 2.38 higher) |
11 (1 RCT) |
⊕⊝⊝⊝ very lowc |
|
Dyspnoea ‐ change in mMRC Scale 0 to 4. Lower is better and 1 unit is a clinically important difference |
Mean change = ‐0.75 units | Mean change in mMRC score in the AMBMT group was 0.00 units lower (95% CI 0.37 lower to 0.37 higher) |
127 (2 RCTs) |
⊕⊝⊝⊝ very lowd |
|
Dyspnoea ‐ change in Borg Scale Borg CR‐10. Scale 0 to 10. Lower is better and 1 unit is a clinically important difference |
Mean change = 0.32 units | Mean change in Borg Scale score in the AMBMT group was 0.44 units lower (95% CI 0.88 to 0.00 lower) |
139 (1 RCT) |
⊕⊝⊝⊝ very lowe |
| Adverse eventsf | ‐ | ‐ | 490 (8 RCTs) | ‐ |
| *The basis for the response on control is the mean control group response across studies AMBMT: active mind‐body movement therapy; CAT: COPD Assessment Test; CI: confidence interval; CRQ: Chronic Respiratory Questionnaire; MD: mean difference; mMRC: modified Medical Research Council Scale; PR: pulmonary rehabilitation; QoL: quality of life; RCT: randomised controlled trial; SGRQ: St. George's Respiratory Questionnaire | ||||
| GRADE Working Group grades of evidence High quality: further research is very unlikely to change our confidence in the estimate of effect Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate Very low quality: we are very uncertain about the estimate | ||||
aAllocation concealment was unclear in all studies, no study reported blinding of assessors (1 reported high risk), one study had an attrition bias greater than 20%, and one study had unbalanced groups at baseline (‐1 for risk of bias). The exercise component of PR was not consistent with recommendations, i.e., two studies consisted of walking recommendations alone with little (recommendation to walk 30 minutes daily) or no information on duration and no information on intensity nor progression of walking training (‐1 for indirectness). In addition, an adequate sample size calculation was not made in any study, the 95% confidence interval crosses the limit for clinically important difference but did not include "no effect"
bMost risk of bias items were rated unclear, including allocation concealment, incomplete outcome data, and selective reporting, in addition to high risk of bias for blinding of participants and outcome assessment (‐1 for risk of bias). The exercise component of PR was not consistent with recommendations, i.e., exercise training consisted of walking recommendations alone with little (recommendation to walk 30 minutes daily) duration and no information on intensity nor progression of walking training (‐1 indirectness). In addition, an adequate sample size calculation was not made, the 95% confidence interval crosses the limit for clinically important difference but did not include "no effect"
cNo blinding of outcome assessors, selective reporting, unbalanced group sizes at baseline (‐1 for risk of bias). One small sample study only, and no sample size calculation for selected outcome (‐1 inconsistency). The 95% confidence limit crosses the limit for clinically important differences as well as the limit for "no effect" (‐1 for imprecision)
dMost risk of bias items were rated unclear, including allocation concealment, incomplete outcome data, selective reporting (‐1 for risk of bias). The exercise component of PR was not consistent with recommendations, i.e., exercise training consisted of walking recommendations alone with little or no information on duration, intensity, nor progression of walking training in both studies (‐1 indirectness). No sample size calculation in any study, the 95% confidence limit crosses the limit for clinically important differences as well as the limit for "no effect" (‐1 for imprecision)
eNo blinding of outcome assessors, selective reporting, unbalanced group sizes at baseline (‐1 for risk of bias). One small sample study only, and no sample size calculation for selected outcome (‐1 inconsistency) The 95% confidence limit crosses the limit for clinically important differences as well as the limit for "no effect" (‐1 for imprecision)
fNo studies reported adverse events
Summary of findings 2. Summary of findings for AMBMT + PR vs PR.
| Active mind‐body movement therapies (AMBMTs) + pulmonary rehabilitation (PR) vs PR for chronic obstructive pulmonary disease | ||||
|
Patient or population: patients with chronic obstructive pulmonary disease Settings: any setting Intervention: AMBMT + PR Control: PR | ||||
| Outcomes | Illustrative comparative risks* (95% CI) | No. of participants (studies) | Quality of the evidence (GRADE) | |
| Response on control | Treatment effect | |||
| PR | AMBMT + PR vs PR | |||
|
QoL ‐ SF‐36 general Health Scale 0 to 100. Higher is better |
Mean change = ‐4.00 units | Mean change in SF‐36 general health score in the AMBMT + PR group was 5.42 units higher (95% CI 3.82 to 7.02 higher) |
80 (1 RCT) | ⊕⊝⊝⊝ very lowa |
|
QoL ‐ SF‐36 mental health Scale 0 to 100. Higher is better |
Mean change = ‐3.10 units | Mean change in SF‐36 mental health score in the AMBMT + PR group was 3.2 units higher (95% CI 1.45 to 4.95 to higher) |
80 (1 RCT) | ⊕⊝⊝⊝ very lowa |
|
QoL ‐ Change in SGRQ total score Scale 0 to 100. Lower is better and 4 units is a clinically important difference |
Mean change = ‐3.72 units | Mean change in SGRQ total score in the AMBMT + PR group was 2.57 units lower (95% CI 7.76 lower to 2.62 higher) |
192 (1 RCT) | ⊕⊕⊕⊝ moderateb |
|
Dyspnoea ‐ CRQ dyspnoea Scale 1 to 7. Higher is better and 0.5 units is a clinically important difference |
Mean change = 0.25 units | Mean change in CRQ dyspnoea score in the AMBMT + PR group was 0.04 units higher (95% CI 2.18 lower to 2.26 higher) |
80 (1 RCT) | ⊕⊝⊝⊝ very lowc |
| Adverse eventsd | ‐ | ‐ | 272 (2 RCT) | ‐ |
| *The basis for the response on control is the mean control group response across studies AMBMT: active mind‐body movement therapy; CI: confidence interval; CRQ: Chronic Respiratory Questionnaire; MD: mean difference; PR: pulmonary rehabilitation; RCT: randomised controlled trial; SGRQ: St. George's Respiratory Questionnaire | ||||
| GRADE Working Group grades of evidence High quality: further research is very unlikely to change our confidence in the estimate of effect Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate Very low quality: we are very uncertain about the estimate | ||||
aRandom sequence generation and blinding of assessors reported but no allocation concealment and incomplete outcome data while selective reporting was unclear (‐1 for risk of bias). The exercise component of PR was not consistent with recommendations, i.e., exercise training consisted of walking recommendations alone with no information on duration, intensity, nor progression of walking training (‐1 for indirectness). One study only, low number of events, optimal information size not met, and no sample size calculation made for this outcome (‐1 for imprecision). In addition, no information on clinically important differences is available for this outcome but the 95% confidence interval did not include "no effect"
bRandom sequence generation, allocation concealment, blinding of assessors, no selective reporting reported as well as intention to treat. However, attrition > 20% and one study only (‐1 for risk of bias/overall downgrade). The exercise component of PR is consistent with recommendations. In addition, a sample size calculation was made for the selected outcome, the 95% confidence interval did cross the limit for clinically important difference but did not include "no effect"
cRandom sequence generation and blinding of assessors reported but no allocation concealment and incomplete outcome data while selective reporting was unclear (‐1 for risk of bias). The exercise component of PR was not consistent with recommendations, i.e., exercise training consisted of walking recommendations alone with no information on duration, intensity, nor progression of walking training (‐1 for indirectness). One study only, low number of events, optimal information size not met, no sample size calculation made for this outcome, the 95% confidence limit crosses the limit for clinically important differences as well as the limit for "no effect" (‐1 for imprecision)
dNo studies reported adverse events
AMBMT versus PR
Comparisons of AMBMT versus PR included all participants of included studies who were randomly allocated to either AMBMT or PR (see Characteristics of included studies for additional information).
Primary outcomes
Disease‐specific quality of life
Four studies including a total of 381 participants used three different questionnaires ‐ the SGRQ, the CAT, and the Zhongsan COPD Questionnaire ‐ to assess disease‐specific quality of life (Chan 2010; Du 2013; Liu 2012; Yang 2009). The SGRQ and the CAT are validated questionnaires that are commonly used among patients with COPD; the Zhongsan COPD Questionnaire, even though it is not commonly used in Western countries, has established validity and reliability in a Chinese population (Cai 2004). The Zhongsan COPD Questionnaire consists of 35 questions, clustered into four categories: 13 questions for activities of daily living (ADLs), seven for social participation, eight for depression, and seven for anxiety. Each question is rated on a 4‐point scale, and lower marks indicate better QoL (Liu 2012). Investigators performed separate analyses of questionnaire results.
On the SGRQ (Figure 4), results favoured AMBMT for total score (mean difference (MD) ‐5.83, 95% confidence interval (CI) ‐8.75 to ‐2.92; 249 participants; low‐quality evidence; Analysis 1.1), subscale activity (MD ‐8.96, 95% CI ‐13.04 to ‐4.89; 213 participants; low‐quality evidence; Analysis 1.1), and subscale impact (MD ‐3.75, 95% CI ‐6.78 to ‐0.73; 213 participants; low‐quality evidence; Analysis 1.1) but showed no difference in subscale symptoms (MD ‐2.22, 95% CI ‐5.66 to 1.23; 213 participants; low‐quality evidence; Analysis 1.1). For SGRQ subscale activity and for SGRQ total score, the common effect size exceeded the MCID of minus four for the SGRQ (Jones 2005), and the 95% CI around the pooled treatment effect did not exceed the MCID.
4.

Forest plot of comparison: 1 AMBMT vs PR, outcome: 1.1 SGRQ.
1.1. Analysis.
Comparison 1 AMBMT vs PR, Outcome 1 SGRQ.
One study used the CAT (Du 2013). Results favoured AMBMT over PR (MD ‐6.58, 95% CI ‐9.16 to ‐4.00; 74 participants; low‐quality evidence; Analysis 1.2), and both the common effect size and the lower limit of the confidence interval exceeded the MCID of three (Alma 2016). Results show no differences between AMBMT and PR alone for any of the CRQ subscales (Figure 5): dyspnoea (MD ‐0.21, 95% CI ‐2.81 to 2.38; 11 participants; very low‐quality evidence; Analysis 1.3), fatigue (MD ‐0.98, 95% CI ‐2.28 to 0.32; 11 participants; very low‐quality evidence; Analysis 1.3), mastery (MD ‐0.31, 95% CI ‐1.44 to 0.82; 11 participants; very low‐quality evidence; Analysis 1.3), or emotion (MD ‐0.43, 95% CI ‐1.16 to 0.29; 11 participants; very low‐quality evidence; Analysis 1.3). Last, with regard to the Zhongsan COPD Questionnaire, results favoured AMBMT for ADL (MD ‐1.66, 95% CI ‐2.98 to ‐0.34; 83 participants; very low‐quality evidence; Analysis 1.4) and showed no differences between AMBMT and PR for social participation (MD ‐0.09, 95% CI ‐0.96 to 0.78; 83 participants; very low‐quality evidence; Analysis 1.4), depression (MD ‐0.61, 95% CI ‐1.35 to 0.13; 83 participants; very low‐quality evidence; Analysis 1.4), or anxiety (MD ‐0.62, 95% CI ‐1.78 to 0.54; 83 participants; very low‐quality evidence; Analysis 1.4). To our knowledge, no MCID is available for the Zhongsan COPD Questionnaire; this precludes assessment of clinical significance.
1.2. Analysis.
Comparison 1 AMBMT vs PR, Outcome 2 CAT.
5.

Forest plot of comparison: 1 AMBMT vs PR, outcome: 1.3 CRQ.
1.3. Analysis.
Comparison 1 AMBMT vs PR, Outcome 3 CRQ.
1.4. Analysis.
Comparison 1 AMBMT vs PR, Outcome 4 Zhongshan COPD Questionnaire.
Generic heath‐related quality of life
None of the trials included in the review addressed this particular outcome.
Dyspnoea
Four studies involving 277 participants measured dyspnoea during exercise (6MWT via Borg Scale) or during daily living (modified Medical Research Council Scale (mMRC) or CRQ Dyspnoea) (Chan 2010; Du 2013; Papp 2017; Zhu 2010). Neither statistically nor clinically significant differences were evident on the Borg Scale (MD ‐0.44, 95% CI ‐0.88 to 0.00; 139 participants; very low‐quality evidence; Analysis 1.5), the mMRC (MD 0.00, 95% CI ‐0.37 to 0.37; 127 participants; very low‐quality evidence; Analysis 1.6), or the CRQ Dyspnoea domain (MD ‐0.21, 95% CI ‐2.81 to 2.38; 11 participants; very low‐quality evidence; Analysis 1.3).
1.5. Analysis.
Comparison 1 AMBMT vs PR, Outcome 5 Borg CR10 ‐ Dyspnoea.
1.6. Analysis.
Comparison 1 AMBMT vs PR, Outcome 6 mMRC.
Serious adverse events
None of the trials included in the review addressed this particular outcome.
Secondary outcomes
Exercise capacity
Seven studies involving a total of 436 participants used the 6MWT to assess functional exercise capacity. Researchers found no statistically or clinically significant differences between AMBMT and PR (MD 3.05 m, 95% CI ‐9.97 to 16.07; 436 participants; low‐quality evidence; Analysis 1.7). The 6MWT demonstrated substantial heterogeneity in the results obtained. Therefore, investigators performed a subgroup analysis based on the type of AMBMT performed and found no statistically or clinically significant differences between tai chi and PR (three studies; Chan 2010; Du 2013; Niu 2014), or between qigong and PR (three studies; Liu 2012; Yang 2009; Zhu 2010), but they noted a significant difference between yoga and PR favouring the PR group (MD 69.3 m, 95% CI ‐117.7 to ‐20.9; 11 participants; very low‐quality evidence; test for subgroup differences: Chi² = 11.01, df = 2 (P = 0.004), I² = 81.8%) (Papp 2017). One trial used incremental and constant work rate cycle ergometry to assess exercise capacity and reported no between‐group differences in peak oxygen uptake (VO₂) (MD 55 mL/min, 95% CI ‐157.8 to 267.8; 36 participants; very low‐quality evidence; Analysis 1.8) nor in constant work rate exercise time (MD 0.14 min, 95% CI ‐1.8 to 2.1; 36 participants; very low‐quality evidence, Analysis 1.9).
1.7. Analysis.
Comparison 1 AMBMT vs PR, Outcome 7 6MWD.
1.8. Analysis.
Comparison 1 AMBMT vs PR, Outcome 8 ICE.
1.9. Analysis.
Comparison 1 AMBMT vs PR, Outcome 9 CWR.
Pulmonary function
Researchers found no statistically or clinically significant differences between AMBMT and PR in FEV₁ (MD 0.07 L, 95% CI ‐0.01 to 0.15; 318 participants; low‐quality evidence; Analysis 1.10) nor in FVC (MD ‐0.02 L, 95% CI ‐0.21 to 0.17; 150 participants; low‐quality evidence; Analysis 1.11). Statistical differences favoured AMBMT over PR for the FEV₁/FVC ratio (MD 3.84%, 95% CI 0.68 to 7.01; 260 participants; low‐quality evidence; Analysis 1.12) and for FEV₁ predicted (MD 3.95%, 95% CI 1.77 to 6.13; 325 participants; low‐quality evidence; Analysis 1.13). Trial results showed no heterogeneity for FEV₁ nor for FVC and FEV₁ predicted but substantial heterogeneity for the FEV₁/FVC ratio. Subgroup analysis performed on the type of AMBMT revealed that heterogeneity for the FEV₁/FVC ratio was absent when Du 2013, which included only patients with mild to moderate COPD, was removed from the analysis. Furthermore, no statistical differences were evident for the FEV₁/FVC ratio (MD 2.70%, 95% CI ‐0.49 to 5.89; 186 participants; low‐quality evidence) nor for FEV₁ predicted (MD 2.65%, 95% CI ‐0.71 to 6.00; 251 participants; low‐quality evidence).
1.10. Analysis.
Comparison 1 AMBMT vs PR, Outcome 10 FEV₁.
1.11. Analysis.
Comparison 1 AMBMT vs PR, Outcome 11 FVC.
1.12. Analysis.
Comparison 1 AMBMT vs PR, Outcome 12 FEV₁/FVC.
1.13. Analysis.
Comparison 1 AMBMT vs PR, Outcome 13 FEV₁ predicted.
Limb muscle function
None of the trials included in this review addressed this particular outcome.
Acute exacerbations
Liu 2012 included a comparison of AMBMT versus PR for acute exacerbations and found no differences between conditions (MD 0.03, 95% CI ‐0.21 to 0.27; 83 participants; very low‐quality evidence; Analysis 1.14).
1.14. Analysis.
Comparison 1 AMBMT vs PR, Outcome 14 AECOPD.
Adherence
None of the trials included in the review addressed this particular outcome.
AMBMT + PR versus PR
Comparisons of AMBMT + PR versus PR alone included all participants of included studies (Ng 2011; Ng 2014). See Characteristics of included studies for additional information. No subgroup analyses were performed, as results showed no heterogeneity for the main comparisons.
Primary outcomes
Disease‐specific quality of life
AMBMT added to PR versus PR alone did not result in any difference in SGRQ total score (MD ‐2.57, 95% CI ‐7.76 to 2.62; 192 participants; moderate‐quality evidence; Analysis 2.1) nor in any of the SGRQ subscales (Figure 6): activity (MD ‐3.79, 95% CI ‐9.98 to 2.40; 192 participants; moderate‐quality evidence; Analysis 2.1), symptoms (MD ‐0.11, 95% CI ‐5.71 to 5.49; 192 participants; moderate‐quality evidence; Analysis 2.1), or impact (MD ‐2.64, 95% CI ‐8.11 to 2.83; 192 participants; moderate‐quality evidence; Analysis 2.1). Nor did the 95% confidence interval around the pooled treatment effect or the common effect size exceed the MCID of minus four (Jones 2005). Results show no additional benefits of AMBMT + PR versus PR alone for any of the CRQ subscales (Figure 7): dyspnoea (MD 0.04, 95% CI ‐2.18 to 2.26; 80 participants; very low‐quality evidence; Analysis 2.2), fatigue (MD 0.18, 95% CI ‐1.48 to 1.84; 80 participants; very low‐quality evidence; Analysis 2.2), mastery (MD 0.27, 95% CI ‐2.78 to 3.32; 80 participants; very low‐quality evidence; Analysis 2.2), or emotion (MD 0.31, 95% CI ‐2.62 to 3.24; 80 participants; very low‐quality evidence; Analysis 2.2). Nor did the 95% confidence interval around the pooled treatment effect or the common effect size exceed the MCID of 0.5 (Jaeschke 1989).
2.1. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 1 SGRQ.
6.

Forest plot of comparison: 2 PR with AMBMT vs PR, outcome: 2.1 SGRQ.
7.

Forest plot of comparison: 2 PR with AMBMT vs PR, outcome: 2.2 CRQ.
2.2. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 2 CRQ.
Generic health‐related quality of life
One study including 80 participants used the SF‐36 questionnaire to assess generic quality of life. Results favoured AMBMT + PR over PR alone for the SF‐36 general health subscale (MD 5.42, 95% CI 3.82 to 7.02; 80 participants; very low‐quality evidence; Analysis 2.3) and the SF‐36 mental health subscale (MD 3.20, 95% CI 1.45 to 4.95; 80 participants; very low‐quality evidence; Analysis 2.3).
2.3. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 3 SF‐36.
Dyspnoea
Trial results show no additional benefits of AMBMT + PR versus PR alone for the CRQ dyspnoea subscale (MD 0.04, 95% CI ‐2.18 to 2.26; 80 participants; very low‐quality evidence; Analysis 2.2). Neither statistically nor clinically significant differences were seen on the Borg Scale (MD ‐0.10, 95% CI ‐0.37 to 0.17; 192 participants; low‐quality evidence; Analysis 2.4), nor in the Self‐efficacy for Managing Shortness of Breath Scale (SEMSOB) (MD 0.23, 95% CI ‐0.30 to 0.76; 192 participants; very low‐quality evidence; Analysis 2.5) or the COPD Self‐efficacy Scale (CSES) (MD ‐0.00, 95% CI ‐0.04 to 0.04; 11 participants; very low‐quality evidence; Analysis 2.6).
2.4. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 4 Borg CR10 ‐ Dyspnoea.
2.5. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 5 SEMSOB.
2.6. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 6 CSES.
Serious adverse events
None of the trials included in this review addressed this particular outcome.
Secondary outcomes
Exercise capacity
Researchers used the 6MWT to assess functional exercise capacity and found no statistically or clinically significant differences between AMBMT + PR and PR alone (MD 14.1 m, 95% CI ‐3.68 to 31.86; 272 participants; moderate‐quality evidence; Analysis 2.7).
2.7. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 7 6MWD.
Pulmonary function
Trial results show no statistically or clinically significant differences between AMBMT and PR versus PR alone in FEV₁ (MD 0.06 L, 95% CI ‐0.09 to 0.21; 192 participants; low‐quality evidence; Analysis 2.8), in FVC (MD 0.13 L, 95% CI ‐0.09 to 0.35; 192 participants; low‐quality evidence; Analysis 2.9), nor in FEV₁ predicted (MD 3.04%, 95% CI ‐4.39 to 10.47; 192 participants; low‐quality evidence; Analysis 2.10).
2.8. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 8 FEV₁.
2.9. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 9 FVC.
2.10. Analysis.
Comparison 2 AMBMT with PR vs PR, Outcome 10 FEV₁ predicted.
Limb muscle function
None of the trials included in this review addressed this particular outcome.
Exacerbations
None of the trials included in this review addressed this particular outcome.
Adherence
None of the trials included in this review addressed this particular outcome.
Discussion
Summary of main results
The primary aim of this review was to determine whether active mind‐body movement therapy (AMBMT) compared with pulmonary rehabilitation (PR), or in addition to PR, would further improve quality of life, symptoms of dyspnoea, and exercise capacity in people with chronic obstructive pulmonary disease (COPD). We included in this review 10 studies with 762 participants; of these, eight studies compared AMBMT versus a conventional PR programme, and two compared the effect of adding AMBMT to PR.
A vast majority of included studies used the term 'PR' uncritically (e.g. unstructured walking training (often self‐paced) was the sole component of PR in seven out of 10 included studies), thus making an adequate comparison of AMBMT and PR difficult.
With regard to the comparison of AMBMT versus PR for primary outcomes, we obtained results related to the Chronic Respiratory Questionnaire (CRQ), the COPD Assessment Test (CAT), and the Borg Scale from a single study. We found a statistically and clinically significant effect favouring AMBMT over PR in quality of life assessed by St. George's Respiratory Questionnaire (SGRQ) total score (three studies) and CAT score. Trial results show no significant differences in the CRQ domains of fatigue, emotion, and mastery. Three studies using different tools to measure levels of dyspnoea (CRQ, modified Medical Research Council Scale (mMRC), Borg Scale) found no significant differences between AMBMT and PR.
Comparison of AMBMT added to PR versus PR alone revealed a statistically significant difference favouring AMBMT added to PR for quality of life measured by Short Form (SF)‐36 for general and mental health. However, researchers observed no significant differences for disease‐specific quality of life (QoL), assessed by the SGRQ total score. They also found no significant differences between AMBMT added to PR and PR alone for dyspnoea measured by the dyspnoea domain of the CRQ. However, all of these results were drawn from a single study and cannot be conclusive; further research is needed for firm conclusions about the effects of AMBMT added to PR.
We have provided further information regarding main trial results and quality of the evidence in Table 1 and Table 2.
Overall completeness and applicability of evidence
Most studies in this meta‐analysis investigated QoL as well as dyspnoea. Furthermore, different trials recruited participants with a wide range of airflow limitations (Global Initiative on Obstructive Lung Disease (GOLD) stages 1 to 4). One study excluded patients with very severe COPD, and another included only patients with mild and moderate COPD (GOLD stages 1 and 2). Interventions included qigong techniques, tai chi, and yoga. Conclusions on the effects of yoga in COPD are highly limited owing to the small number of patients with COPD who were included and the unbalanced group allocation (Papp 2017). Most studies comparing AMBMT versus walking interventions satisfied the PR definition provided in our review (see Types of interventions) but do not conform to current recommendations (Garvey 2016; Spruit 2013). The small number of randomised controlled trials identified, the inadequate descriptions of PR programmes provided, and the lack of information detailing aspects related to risk of bias make it challenging to draw firm conclusions about the effects of AMBMT in COPD.
Quality of the evidence
We used the GRADE system to rate the quality of evidence for the main comparisons. In the comparison of AMBMT versus PR, the quality of evidence was low for disease‐specific QoL, and very low for dyspnoea. The main reasons for downgrading the quality of evidence were limitations in study quality and possible indirectness in study results, mainly due to the fact that study authors poorly described the training component of PR (e.g. no information on duration or intensity of the walking training performed). Evidence for the comparison of AMBMT + PR versus PR alone was also of low quality for generic QoL. We attributed this to limitations in study quality, indirectness in study results, and the small number of events reported by a single study without adequate sample size calculation for this outcome. In this comparison, the quality of evidence for disease‐specific QoL ranged from moderate to very low. We have provided reasons for downgrading the quality of evidence in Table 1 and Table 2.
Potential biases in the review process
Two review authors (LMcG and AN) independently reviewed all articles throughout each step of the inclusion process. Agreement between the two review authors was excellent, as is reflected by a kappa of 0.90. Also, two review authors independently extracted data, assessed risk of bias, and resolved discrepancies by discussion with a third review author (YL). If necessary, we contacted the authors of individual studies to ask for missing or additional information. We used only published data, potentially influencing the calculated treatment effect.
Agreements and disagreements with other studies or reviews
To date, seven systematic reviews and meta‐analyses have examined the effects of AMBMT strategies, mainly tai chi and/or qigong, in people with COPD (Chen 2016; Ding 2014; Guo 2016;Ng 2014a; Ngai 2016; Wu 2014; Yan 2013).
Chen 2016 included tai chi as the AMBMT strategy that was compared with usual care. Yan 2013 and Guo 2016 also included tai chi as the AMBMT strategy. However, researchers compared tai chi versus several different control interventions (e.g. usual care, exercise training, respiratory exercises, drug therapy), all of which were pooled together. Thus, results reported in these reviews may be different from results reported in the present review, and a direct comparison between reviews is not appropriate.
Similar to the present review, Wu 2014 included comparisons of tai chi versus exercise training, and Ng 2014a and Ngai 2016 included comparisons of tai chi and/or qigong + exercise training versus exercise training alone. However, in Wu 2014 and Ng 2014a, researchers considered different types and combinations of breathing exercises alone as exercise training. Thus the definitions of exercise training used in these reviews are not the same as the definition used in the present review, and this precludes direct comparisons of results (Garvey 2016; Spruit 2013).
In Ngai 2016, investigators compared AMBMT (tai chi) and PR versus PR alone using the same definition of PR that was provided in the present review. With regard to effects of AMBMT (tai chi) added to PR on disease‐specific QoL, pulmonary function, and six‐minute walking distance (6MWD), the present review did not include any studies other than those included by Ngai 2016 thus, the results for these outcomes are similar between reviews. However, in contrast to Ngai 2016, the present review included additional outcomes such as dyspnoea, generic quality of life for additional AMBMT strategies (qigong and yoga), and a comparison of AMBMT versus PR alone.
Last, Ding 2014 included three studies that evaluated the effects of tai chi and seven studies that evaluated the effects of qigong, three of which included a comparison of the effects of tai chi and/or qigong versus PR on walking distance and lung function. Similar to the present review, exercise training within PR mainly consisted of walking training. Researchers found no differences in walking distance on the 6MWD nor in forced expiratory volume in one second (FEV₁) between tai chi/qigong and PR; this is similar to the findings reported for AMBMT versus PR in the present review. Review authors performed a subanalysis in which the PR group was divided into one group for which exercise intensity of the walking training was controlled and another group for which it was uncontrolled. Review authors found a larger increase in walking distance on the 6MWD with tai chi/qigong over PR when exercise intensity was uncontrolled and noted no difference when it was controlled. Thus, the difference in results between uncontrolled and controlled intensity emphasises the importance of using PR of adequate design for accurate comparisons.
Limited information on duration and progression of the training programmes used as comparators is a major limitation for interpretation of the walking training provided in included studies in both the present and previous reviews on this topic. As recommended in the latest American Thoracic Society (ATS)/European Respiratory Society (ERS) statement on PR, the following exercise training principles are mandatory for the design of an effective PR programme, irrespective of the exercise modality used (Spruit 2013): (1) the total training load must reflect the individual's specific requirements, (2) the training load must exceed loads encountered during daily life, and (3) adequate duration, intensity, and progression of training are essential. This information should be reflected in the final trial report.
Authors' conclusions
Implications for practice.
The fact that unstructured walking training was the sole component of PR in most included studies makes it challenging to draw firm conclusions about the effects of AMBMT compared with or provided as an adjunct to PR. Results of this meta‐analysis indicate that clinically relevant improvements in disease‐specific QoL may be seen with AMBMT when compared with PR. However, the quality of evidence for this is low, and our confidence in this observed effect is therefore highly limited. Similarly, the low quality of evidence for the dyspnoea data provided limits our conclusions about these results. Results of this meta‐analysis also indicate that AMBMT added to PR may be more effective than PR alone for improving generic QoL (very low‐quality evidence) but not disease‐specific QoL in this population (moderate‐ to very low‐quality evidence). The overall poor quality of evidence derived from the comparison of AMBMT + PR versus PR alone limits our confidence in these results. Thus, limited available findings showing effects of AMBMT versus PR or of AMBMT added to PR versus PR alone remain inconclusive.
Implications for research.
The small number of included studies, the low overall quality of study methods and evidence, vast differences in the definitions of PR provided within studies, and the predominance of studies from China, reducing generalisation of the results, highlight that further studies comparing AMBMT as an adjunct to PR or versus PR alone are warranted. Future studies should include PR programmes that are properly designed and reported in accordance with current recommendations and guidelines (Garvey 2016; Spruit 2013). These programmes should be delivered by properly trained professionals who have a comprehensive understanding of respiratory physiology, exercise science, and the pathology of COPD. Furthermore, in addition to measurements of QoL, dyspnoea, and exercise capacity, assessment of the potential effects of AMBMT on limb muscle function parameters such as limb muscle strength, endurance, and/or fatigue is warranted, given the negative consequences of limb muscle dysfunction for this population (Maltais 2014). Future studies are also needed to evaluate the impact of AMBMT strategies on patients after an exacerbation of COPD. Finally, given the different types of AMBMT strategies included in the present review, additional studies are needed to examine the individual influence of each of these different strategies.
Acknowledgements
We thank Ms Andrea Falk for her assistance with Chinese translation.
Sally Spencer was the Editor for this review and commented critically on the review.
The Background and Methods sections of this review are based on a standard template used by Cochrane Airways.
This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Airways Group. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.
Appendices
Appendix 1. Sources and search methods for the Cochrane Airways Group Specialised Register (CAGR)
Electronic searches: core databases
| Database | Frequency of search |
| CENTRAL (the Cochrane Library) | Monthly |
| MEDLINE (Ovid) | Weekly |
| Embase (Ovid) | Weekly |
| PsycINFO (Ovid) | Monthly |
| CINAHL (EBSCO) | Monthly |
| AMED (EBSCO) | Monthly |
Handsearches: core respiratory conference abstracts
| Conference | Years searched |
| American Academy of Allergy, Asthma and Immunology (AAAAI) | 2001 onwards |
| American Thoracic Society (ATS) | 2001 onwards |
| Asia Pacific Society of Respirology (APSR) | 2004 onwards |
| British Thoracic Society Winter Meeting (BTS) | 2000 onwards |
| Chest Meeting | 2003 onwards |
| European Respiratory Society (ERS) | 1992, 1994, 2000 onwards |
| International Primary Care Respiratory Group Congress (IPCRG) | 2002 onwards |
| Thoracic Society of Australia and New Zealand (TSANZ) | 1999 onwards |
MEDLINE search strategy used to identify trials for the CAGR
COPD search
1. Lung Diseases, Obstructive/
2. exp Pulmonary Disease, Chronic Obstructive/
3. emphysema$.mp.
4. (chronic$ adj3 bronchiti$).mp.
5. (obstruct$ adj3 (pulmonary or lung$ or airway$ or airflow$ or bronch$ or respirat$)).mp.
6. COPD.mp.
7. COAD.mp.
8. COBD.mp.
9. AECB.mp.
10. or/1‐9
Filter to identify RCTs
1. exp "clinical trial [publication type]"/
2. (randomized or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1‐7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
The MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases.
Appendix 2. Search strategy to identify trial reports from the Airways Register (via the Cochrane Register of Studies platform)
#1 MeSH DESCRIPTOR Pulmonary Disease, Chronic Obstructive Explode All
#2 MeSH DESCRIPTOR Bronchitis, Chronic
#3 (obstruct*) near3 (pulmonary or lung* or airway* or airflow* or bronch* or respirat*)
#4 COPD:MISC1
#5 (COPD OR COAD OR COBD OR AECOPD):TI,AB,KW
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 MeSH DESCRIPTOR Tai Ji
#8 "tai ji"
#9 taiji
#10 "t'ai chi"
#11 "tai chi"
#12 taichi
#13 shadow NEXT boxing
#14 MeSH DESCRIPTOR Yoga
#15 yoga*
#16 Pranayam*
#17 asana*
#18 qigong*
#19 "qi gong" or qi‐gong
#20 "chi gong" or chi‐gong
#21 "Chi kung"
#22 Baduanjin
#23 Yinjinjing
#24 "Yinjin jing"
#25 "wu qin xi"
#26 wuqinxi
#27 "Zhan Zhuang"
#28 pilates*
#29 mind* NEAR2 body*
#30 meditat* NEAR3 (exercis* OR movement*)
#31 #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30
#32 #6 and #31
[Note: in search line #4, MISC1 denotes the field in the record where the reference has been coded for condition, in this case, COPD]
Appendix 3. Search strategy or keywords used for non‐CAGR databases
COPD filter
"阻塞性肺病" (obstructive lung disease)
"copd"
"慢性阻塞性呼吸道病" (coad, chronic obstructive airways disease)
"急性加剧慢性支气管炎" (aecb, acute exacerbations chronic bronchitis)
"慢性呼吸道限制" (chronic airway limitation)
"肺气肿" (pulmonary emphysema)
"慢性支气管炎" (chronic bronchitis)
AMBMT filter
"太极拳" (tai ji quan)
"瑜伽" (Yoga)
"气功" (Qigong)
"气功疗法" (Qigong therapy)
"气功治疗" (Qigong treatment)
"气功组" (Qigong group)
"中医气功" (medical Qigong)
"气功锻炼" (Qigong training)
"健身气功" (fitness qigong)
"八段锦" (Baduanjin)
"易筋经" (Yi jin jing)
"五禽戏" (Wu qin xi)
"形神" (Mind and body)
"普拉提" (Pilates)
"练功" (Liangong)
"tai chi"
"Qigong"
"Yoga"
"Pilates"
Data and analyses
Comparison 1. AMBMT vs PR.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 SGRQ | 3 | Mean Difference (IV, Random, 95% CI) | Subtotals only | |
| 1.1 Total | 3 | 249 | Mean Difference (IV, Random, 95% CI) | ‐5.83 [‐8.75, ‐2.92] |
| 1.2 Activity | 2 | 213 | Mean Difference (IV, Random, 95% CI) | ‐8.96 [‐13.04, ‐4.89] |
| 1.3 Impact | 2 | 213 | Mean Difference (IV, Random, 95% CI) | ‐3.75 [‐6.78, ‐0.73] |
| 1.4 Symptoms | 2 | 213 | Mean Difference (IV, Random, 95% CI) | ‐2.22 [‐5.66, 1.23] |
| 2 CAT | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 3 CRQ | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 3.1 Dyspnoea | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 3.2 Fatigue | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 3.3 Mastery | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 3.4 Emotion | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 4 Zhongshan COPD Questionnaire | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 4.1 ADL | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 4.2 Social participation | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 4.3 Depression | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 4.4 Anxiety | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 5 Borg CR10 ‐ Dyspnoea | 1 | Mean Difference (IV, Fixed, 95% CI) | Totals not selected | |
| 6 mMRC | 2 | 127 | Mean Difference (IV, Random, 95% CI) | 0.00 [‐0.37, 0.37] |
| 7 6MWD | 7 | 436 | Mean Difference (IV, Random, 95% CI) | 3.05 [‐9.97, 16.07] |
| 7.1 Tai chi | 3 | 253 | Mean Difference (IV, Random, 95% CI) | 19.22 [‐1.86, 40.30] |
| 7.2 Qigong | 3 | 172 | Mean Difference (IV, Random, 95% CI) | ‐0.16 [‐10.11, 9.80] |
| 7.3 Yoga | 1 | 11 | Mean Difference (IV, Random, 95% CI) | ‐69.3 [‐117.73, ‐20.87] |
| 8 ICE | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 9 CWR | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 10 FEV₁ | 6 | 318 | Mean Difference (IV, Random, 95% CI) | 0.07 [‐0.01, 0.15] |
| 10.1 Tai chi | 2 | 179 | Mean Difference (IV, Random, 95% CI) | 0.10 [‐0.04, 0.24] |
| 10.2 Qigong | 3 | 128 | Mean Difference (IV, Random, 95% CI) | 0.07 [‐0.08, 0.23] |
| 10.3 Yoga | 1 | 11 | Mean Difference (IV, Random, 95% CI) | ‐0.01 [‐0.22, 0.19] |
| 11 FVC | 2 | 150 | Mean Difference (IV, Random, 95% CI) | ‐0.02 [‐0.21, 0.17] |
| 12 FEV₁/FVC | 5 | 260 | Mean Difference (IV, Random, 95% CI) | 3.84 [0.68, 7.01] |
| 12.1 Tai chi | 1 | 74 | Mean Difference (IV, Random, 95% CI) | 6.02 [3.72, 8.32] |
| 12.2 Qigong | 3 | 175 | Mean Difference (IV, Random, 95% CI) | 3.51 [‐1.24, 8.26] |
| 12.3 Yoga | 1 | 11 | Mean Difference (IV, Random, 95% CI) | 1.90 [‐3.41, 7.21] |
| 13 FEV₁ predicted | 6 | 325 | Mean Difference (IV, Random, 95% CI) | 3.95 [1.77, 6.13] |
| 13.1 Tai chi | 2 | 114 | Mean Difference (IV, Random, 95% CI) | 4.97 [2.16, 7.79] |
| 13.2 Qigong | 4 | 211 | Mean Difference (IV, Random, 95% CI) | 2.42 [‐1.07, 5.91] |
| 14 AECOPD | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected |
Comparison 2. AMBMT with PR vs PR.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 SGRQ | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 1.1 Total | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 1.2 Activity | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 1.3 Symptoms | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 1.4 Impact | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 2 CRQ | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 2.1 Dyspnoea | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 2.2 Fatigue | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 2.3 Mastery | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 2.4 Emotion | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 3 SF‐36 | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 3.1 General health | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 3.2 Mental health | 1 | Mean Difference (IV, Random, 95% CI) | 0.0 [0.0, 0.0] | |
| 4 Borg CR10 ‐ Dyspnoea | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 5 SEMSOB | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 6 CSES | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 7 6MWD | 2 | 272 | Mean Difference (IV, Random, 95% CI) | 14.09 [‐3.68, 31.86] |
| 8 FEV₁ | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 9 FVC | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected | |
| 10 FEV₁ predicted | 1 | Mean Difference (IV, Random, 95% CI) | Totals not selected |
Characteristics of studies
Characteristics of included studies [ordered by study ID]
Chan 2010.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
Baseline imbalances
|
|
| Interventions |
AMBMT Participants completed 60‐minute TCQ practice sessions twice a week for 3 months. The TCQ intervention routine consisted of 13 movements of Breathing Regulating TCQ (BRTCQ), which were selected and modified from the 18 movements of Taiji Qigong produced by the Department of Health. The 13 modified forms of BRTCQ were designed for easy learning and for mastery in a shorter period. The 13 BRTCQ forms were referred to 2 TCQ experts to ensure their validity and feasibility for use with COPD clients. The TCQ class was led by a qualified TCQ master. Participants were required to co‐ordinate their breathing with prescribed movements. They were also advised to practice TCQ exercises for an hour every day, apart from the 2 TCQ sessions. A DVD and TCQ pictures were given to each participant to facilitate daily self‐practice. A diary was given to participants, so they could record the frequency of their self‐practice. PR Participants were taught pursed‐lip breathing and diaphragmatic breathing, co‐ordinated with self‐paced walking as a physical exercise. Expiration time was twice the inspiration time to slow down the breathing rate. Participants were instructed to inhale through the nose, push the stomach out, then exhale through pursed lips slowly, while pulling the stomach in. Return demonstrations of breathing techniques were performed by participants to ensure proper practice. Participants were advised to perform breathing and walking exercises for 1 hour, which could be split into 2 or 3 sessions to prevent fatigue. Leaflets with pictures and instructions were given to participants to facilitate daily self‐practice. A diary was also given to each participant for recording the frequency of self‐ practice sessions. The breathing techniques of participants were re‐assessed at the 6‐week and 3‐month time points to ensure that proper skills were maintained. The breathing component in this group was different from that in the TCQ group, as the TCQ group did not require pursed‐lip breathing and placed no restriction on time for breathing in and out. Other group (not of interest for this review)
Time points measured
|
|
| Outcomes |
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Random allocation done via a randomiser software |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Research assistants for data collection were blinded to the study minimise researcher bias; however, quality of life was assessed by participants who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | High risk | To preserve the value of randomisation, an intention‐to‐treat analysis was applied. Data from last observation were carried forward for withdrawals; attrition rate was 23% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | High risk | Confounding bias: unbalanced exacerbation rates at baseline |
Du 2013.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT Participants followed supervised 60‐minute tai chi sessions twice a week plus daily self‐practice (60 minutes with instructional tai chi CD and log book) for a total of 3 months. The tai chi intervention consisted of a 24‐form Yang style routine with breathing co‐ordination. PR Participants were instructed to perform daily 30 minutes of self‐paced walking sessions and 60 minutes of pursed‐lip breathing and diaphragmatic breathing. Participants could split their training into 2 or 3 sessions to prevent fatigue. Leaflets with instructions were given to participants to facilitate daily self‐practice. A diary was given to each participant for recording self‐ practice sessions and was monitored at 6‐week and 3‐month time periods. Other group (not of interest for this review)
Time points measured
|
|
| Outcomes |
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Random number table |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants not blinded to interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Quality of life assessed by participants who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Liu 2012.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT The HQG group received 1 week of HQG training under the supervision of professional HQG coaches, and then were encouraged to participate in a peer‐led weekly practice group thrice a week, lasting 1 hour each time, for 6 months. The adopted HQG protocol was developed by Professor Hong‐Zhu Jin and his team at the Jiangsu Province Hospitals, and development was guided by the following 2 principles. First, it should be based on routines selected from the 4 national standardised HQG protocols: Tendon Changing Classic or Yijinjing (易 筋經), Frolics of Five Animals or Wuqinxi (五禽戲), The Art of Expiration in Producing Six Different Sounds or Liuzijue (六字訣), and Eight Excellent Movements or Baduanjin (八段錦). Second, selected routines should have been studied for their effect in fostering lung health according to TCM principles. PR The conventional PR group also received a similar amount of professional input on coaching pursed‐lip breathing and aerobic exercise (e.g. walking, cycling on static bicycle). Participants were then encouraged to participate in peer‐led weekly walking and ball game activities thrice a week, 1 hour each time, for 6 months. Other group (not of interest for this review)
Time points measured
|
|
| Outcomes |
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Participant allocation list was drawn based on the random order of a block |
| Allocation concealment (selection bias) | Unclear risk | All outcome assessors were blinded to each participant's allocated group as well as to objectives of the study to minimise bias. However, no information on how allocation was kept concealed |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Research assistants for data collection were blind to the study to minimise researcher bias; however, quality of life was assessed by participants who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | To preserve the value of randomisation, an intention‐to‐treat analysis was applied in calculating missing values at other time points. In the case of withdrawals, data were carried forward; attrition rate was 11% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Ng 2011.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
PR + AMBMT Each patient received four 45‐minute training sessions on HQG led by a trained therapist at the ninth, tenth, eleventh, and twelfth sessions of the PR programme, together with a home learning package in the form of audiovisual materials. The specific form of HQG chosen was Baduanjin. It consisted of 8 distinct movement routines, with each movement routine repeated 6 times. The whole protocol usually took 12 to 15 minutes to complete at a usual pace. To address the special needs of patients with COPD, an expert panel review was conducted to assess potential clinical effectiveness. Before the RCT was begun, a field test was conducted to study safety in its application to patients with COPD. To maximise the potential benefits of training, the minimal dosage of the training protocol that experts advised was practice at least 1 time per day at least 4 times a week until 6‐month follow‐up. To keep a record of their own practice, patients were issued a daily log. PR Each patient received the same number and duration of additional training sessions, reinforcing the breathing (including pursed‐lip and co‐ordinated breathing) and walking exercises of the conventional programme to make it comparable to the treatment group in terms of additional staff attention given to participants. In addition, another set of audiovisual training material on corresponding aspects was issued to all control participants, who were also advised to keep walking daily for not less than 30 minutes until 6‐month follow‐up. Time points measured
|
|
| Outcomes |
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Computer‐generated random numbers |
| Allocation concealment (selection bias) | High risk | The occupational therapist opened the list file and assigned participants to treatment or control group accordingly |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Outcomes assessments were administered by blinded assessors who were ignorant of the treatment arm to which each participant was assigned; however, quality of life was assessed by participants who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | High risk | Analysis was first conducted via the ITT approach, which included all randomised participants classified according to their randomisation and irrespective of their completion of treatment and follow‐up assessments. Missing values at discharge, 3‐month follow‐up, and 6‐month follow‐up were imputed via the "last observation carried forward" method; however, attrition rate was 35% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Ng 2014.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
PR + AMBMT Both groups received rehabilitation consisting of 2 sessions per week for 6 weeks with totally identical content, except that tai chi exercises were added for tai chi group. Data collection was performed at baseline and at 2 and 6 months post intervention. Each session would last for 1 hour and 20 minutes, with 6 to 10 participants per session. Upon entering the intervention protocol, all participants in both groups were required to participate in a 30‐minute educational session conducted by a physiotherapist to improve their knowledge and skills in COPD management. A COPD booklet and home diary were provided as supplementary materials. In the TC group, the formal pulmonary rehabilitation programme was identical to that in the PR group, except that 15 minutes of tai chi exercises was substituted for 15 minutes of relaxation exercise. Five forms of Sun Style tai chi were taught by a tai chi accredited physiotherapist for ease of mastery. The TC group was also instructed to perform 1 hour of daily unsupervised home exercises identical to those performed by the PR group, except for 15 minutes of tai chi replacing the relaxation exercises for 5 to 7 days per week. Both groups were instructed to document their home exercises in their compliance diary. PR Each session would last for 1 hour and 20 minutes with 6 to 10 participants per session. Upon entering the intervention protocol, all participants in both groups were required to participate in the 30‐minute educational session conducted by the physiotherapist to improve their knowledge and skills in COPD management. A COPD booklet and home diary were provided as supplementary materials. The formal pulmonary rehabilitation programme in the PR group would consist of warm‐up and cool‐down exercises and aerobic exercises. Patients performed 5 minutes of warm‐up exercises, then 2 aerobic activities including treadmill and lower limb ergometry exercises, each lasting 20 minutes. A 15‐minute rest period was given between exercises. After aerobic exercises, a 5‐minute cool‐down period was followed by 15 minutes of relaxation exercise conducted before participants completed their session. The PR group was instructed to perform 1 hour of daily unsupervised home exercises consisting of a 5‐minute warm‐up, 5 minutes of Thera‐Band exercises, 30 minutes of aerobic exercises, 5 minutes of cool‐down, and 15 minutes of relaxation exercises for 5 to 7 days a week. Thera‐Band exercises, which utilised a rubber‐based resistance band known to optimise muscle strengthening, were also taught as home exercises for both groups. Both groups were instructed to document home exercises in their compliance diary. |
|
| Outcomes |
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Random number sequences |
| Allocation concealment (selection bias) | Low risk | The same research assistant would conceal the allocation sequence using sequentially numbered envelopes. Each participant would receive 1 envelope that would be opened for allocation to assigned grouping by a different research assistant upon recruitment |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | To minimise researcher bias, research assistants for data collection were blinded to the study; however, quality of life was assessed by participants, who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | High risk | Intention‐to‐treat approach was used for data analysis. For participants lost to follow‐up, the last known data were carried forward to replace missing values; however, attrition rate was 28% |
| Selective reporting (reporting bias) | Low risk | No difference between results of registered study (NCT01259245) and outcomes reported in the manuscript |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Niu 2014.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT Participants in the tai chi group underwent 4 sessions of a supervised tai chi programme and 3 sessions of a home‐based tai chi programme per week, 1 session per day. The entire programme lasted 6 months. Each session consisted of a 10‐minute pre‐exercise warm‐up, followed by 30 minutes of tai chi and 10 minutes of post‐exercise relaxation. The intensity was then adjusted for each patient with COPD according to her/his toleration of the programme. Participants in the tai chi group were trained by a physiotherapist who was an accredited tai chi trainer with extensive experience in chronic lung disease therapy. A tai chi training booklet and DVD developed by an accredited trainer were provided to each participant in the tai chi group for use in home sessions. A workout diary was supplied to all participants to record their practice time for each home session and was routinely checked. Programme adherence for both supervised and at‐home sessions was calculated separately as an average percentage of sessions completed. PR Participants were instructed to walk for 30 minutes daily and were subjected to routine medical care for 6 months after baseline measurement. Routine medical care included, in addition to daily walking, tiotropium 10 mg inhalation and lip breathing for 10 to 15 minutes. |
|
| Outcomes |
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | A computer‐generated randomisation algorithm was adopted to generate treatment assignments |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | Low risk | Outcomes were assessed by researchers who were unaware of the study design |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Attrition rate of 2% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Papp 2017.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT Yoga exercises were based on hatha yoga. Two sessions a week, with sessions extending over 60 to 70 minutes, for 12 weeks, with a total of 24 sessions. Started on chair or meditation chair, in a quiet room without music. Props included yogic blocks and blankets. Exempting questions for the teacher, no talking was permitted during the yoga class. Most participants were novice to yoga. Asanas (eyes open): important instruction throughout class to rest when needed by switching into child pose (balasana), or alternatively to lean forward on the chair with legs apart, and to work at the participant's own capacity. General postural instructions and centreing were given at the beginning of classes. General breathing instructions: extended exhalations, all breathing through nostrils (if possible). Complete deep yogic breathing using the diaphragm extensively during all asanas. Uddiyana bandha (pulling stomach in using pelvic floor muscles first, and then the navel, with light pull in towards the spine during all exhalations) was introduced after approx. 6 weeks. Used complete yogic breathing ‐ 3 levels on inhalation and 3 levels on exhalation. Instructions were given to move hands along with the breathing movement, with inhalation starting at the lower abdominal navel area, then at the upper waist/middle chest and at the upper chest below the clavicles. Exhalation starting at upper chest, then at the middle chest, and finally ending as lower abdominal movement. Vinyasa with back bending tadasana on inhalation and deep utkatasana on exhalation, instruction without arms and then with arms extended above the head, alternatively keeping the hands resting on the shoulders. Utkatasana progressed by sitting all the way down to the chair, and later by squatting all the way down to the floor while letting the heels come up. Ardha Chandrasana (standing side stretch, 1 arm up with the other arm down, the other arm supported on the thigh). Dynamic, then progressed to static holding (approx. 30 seconds on each side) alternatively while sitting on chair if breathing restriction occurred. Trikonasana with chair, foot on floor under chair's seat, and hand on chair's seat or on the back‐rest of the chair. Rotation of head during the final pose. Small sun salutation, dog down and dog up (adho mukha svanasana, urdhva mukha svanasana) dynamic poses with breathing, 4 to 5 times with hands on the seat of the chair. Dog pose with the wall (hands on the wall at shoulder height) was also suggested if no weight on the upper body was possible (approx. 2 minutes). Parsvakonasana with chair with foot under chair's seat and hand on the seat (after 4 to 5 weeks) with emphasis on turning the chest and head. Bharadvajasana, using both sitting and standing variations, with both legs folded to the left and twisted right first. Standing variation (utthita marichyasana), with right side to the wall with right leg up on a chair and with hands used to the wall and twisted to the right (alternative given with block under heel of standing foot), then changing sides. Tiger breathing flow, cat (marjaryasana) and cow, on all fours using extended exhalations. Strong abdominal draw‐in while exhaling. Variation used by some; sitting vertically on a chair using simple back flexion and extension (no weight on arms). Another variation in cat pose consisted of flexion of the wrists on the floor (palms down, thumbs facing out, and palms up, thumbs facing towards each other). Sphinx pose (salamba bhujangasana), walked on underarms to the right, and then to the left. Bhujangasana, resting on abdomen, then arms wide with fingertips facing outwards extending up on inhalation. Setu bhandasana (bridge pose) with 1 leg up, progressed to feet on a chair to achieve inversion. Hip resting on the block with both legs up (viparita dandasana variation), then lowered 1 leg at a time to the floor (stretching hip flexors), then in setu bandha with block. Universal pose: supine twist to the right first with strong abdominal activity and straight spine. Rotation of head opposite the legs to improve neck mobility. Fish pose (matsyasana) supported back bent with yoga block (wood) on thoracic spine behind the heart, to increase mobility in the chest (chest opener), with the option of using a rolled mat or blanket under the chest. Alternative was given with weights on elbows, and alternatively baddha konasana. Yogic breathing exercises (pranayama), sitting on a chair or meditation chair, straight spine, chin slightly lowered (eyes closed, approx. 30 minutes). Asthma mudra was used during some exercises. Metronome was used during the last 5 to 6 weeks to get the timing and awareness of breathing during breathing exercises. Kapalabhati (breath of fire), starting with 10 times worked up to 30 times. Hands on lower abdominals to increase awareness of the abdominals drawing in during exhalation. Slowly first, then trying to speed up the pace. At the end of courses, this involved 20 x 4. Focused on exhalation, with no attention to inhalation, 2 to 3 minutes. Bhastrika, hands on lower abdomen, 20 times. Alternated nostril breathing (nadi shodhana), using nashiki mudra, started exhalation through left nostril, inhaled left, exhaled right, inhaled right, exhaled left. First equal inhaled and exhaled (5 seconds in and 5 seconds out suggested), then tried varied lengths of breathing ratios; 2‐04‐0, 6‐0‐12‐0 with no pauses, with important prolonged exhalation. No pauses after inhalation. Focus on extended exhalations and, if possible, on short pausing after each exhalation, 5 to 10 minutes. Sitkari (inhaled through teeth, exhaled through nose and closed mouth) to be used only during the first 4 to 5 weeks. Bharmari (mmmmm sound on exhalation), humming bee, extended outbreaths ‐ 10 minutes, powerful outbreaths with sound (sometimes with sanmukhi mudra), moved sound to upper back palate and towards third eye. Viloma (Dirghal part breath). Divided inhalations and exhalations into 3 parts, inhalation started at abdomen, same inhalation at middle ribs and last, then at collarbones. Exhalation started at collarbones, middle ribs, abdomen for 2 to 3 minutes (sometimes with prana mudra). Hands moving to the active region of the chest. Sitting at beginning of courses while supined on back at the end. Sukhasana with forward bend, hands on block or chair. Shavasana (body scanning, focus on synchronisation of equal relaxation between left and right sides of the body and letting the weight drop to the floor), sometimes elevated legs with feet or calves on the meditation chair, once during the intervention with weights on thighs. Feet closer than arms, keeping back of shoulders on the floor. Approx. 5 to 8 minutes of home training with this programme was provided on a DVD (in Swedish). The time in each yoga pose was gradually increased, and each pose was held from 5 to 40 seconds; each breathing exercise was performed for a longer duration with fewer pauses towards the end of the intervention. Different variations of poses were gradually introduced (using walls, chairs, and floor). Synchronisation of breathing during exercises was emphasised. Strength was not measured in the HY group. PR Two sessions per week, with sessions extending over 60 to 70 minutes for 12 weeks, including a total of 24 sessions. Working with strength and conditioning equipment (each 2 to 4 sets with 10 to 20 repetitions) and cycling 10 to 15 minutes (intensity ratings of 12 to 14 on Borg 20 Scale, 50 to 60 rpm per minute approx.). Conventional training was performed at a gym (with gym equipment and stationary exercise bikes, adjacent to the yoga room) with background radio/music while 2 physiotherapists coached participants. Participants were allowed to talk to each other and to the physiotherapists, and sometimes to the other participants in the room. Exercises included leg extensions (sitting position), standing arm pull‐backs with thera‐band, sitting leg press, shoulder press, squats to chair with crossed arms in front of chest, seated rowing arm pull‐backs in machine, heel lifts holding back of chair, triceps press in machine, torso rotation in machine, standing biceps curls with free weights, wide sitting on chair and torso twists with stick behind chest, hands resting shoulder height on stick, seated side stretches with extended arm (lower arm resting on hip), shoulder shrugs, seated big upward swimming arm movements with arms above the head. Home programme for pulmonary rehabilitation on a DVD was distributed with the programme on paper. Thera‐bands were supplied for home training. Strength increased during the 12‐week period in the conventional training programme: leg extension by 49%, straight arm pull‐backs by 44.6%, and during leg press by 29.4%, with starting kg/kg increased during the intervention. |
|
| Outcomes | ***Mixed populations; only data from participants with COPD were used and were obtained by contacting study authors.***
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Randomisation was performed by an external person. Blank papers were scattered on a table, with each participant's identification code facing down. Then 1 paper was randomly categorised into the HY group, while the next was categorised into the CTP group, and so on |
| Allocation concealment (selection bias) | Low risk | Randomisation was performed by an external person. Blank papers were scattered on a table, with each participant's identification code facing down. Then 1 paper was randomly categorised into the HY group, while the next was categorised into the CTP group, and so on |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Quality of life was assessed by participants who were not blinded to the interventions |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | Intention‐to‐treat approach was used for data analysis. For participants lost to follow‐up, the last known data were carried forward to replace missing values; attrition rate was 10% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Yang 2009.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT
PR (Western group)
|
|
| Outcomes |
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Randomisation via software PEMS 3.1 |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Attrition rate of 5% |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Zhu 2010.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT Patients underwent daily early morning collective practice, led by an instructor of the 2003 State Sports General Administration of China, New Health Qigong Wu Qinxiu (5 animal frolics). From the starting position to regulate breathing, they went through tiger play, deer play, bear play, ape play, and bird play, and then repeated bird play, and finally returned to original qi position. They repeated this sequence 2 to 3 times. Exercise time and intensity: First week of basic training consisted of learning movements and breathing essentials to master techniques. Practised once every day, each time for 45 minutes, so that the practitioner's heart rate reached the target heart rate, which was maintained for longer than 10 minutes. Practice was adjusted in accordance with the different problems of patients; appropriate adjustment of activity levels involved adjusting the height and strenuousness of movements. Continuous practice for 3 months. Target heart rate: 60 years old and above, heart rate = 170 minus age; younger than 60 years old, heart rate = 180 minus age (exercise intensity was based on the Jungmann formula). PR The walking group was treated with the same conventional therapy with the addition of walking exercises. Every morning, walking was done on a flat surface, speed was maintained at 80 to ˜ 120 steps per minute, with duration of at least 45 minutes, so that the practitioner's heart rate reached the target heart rate, which was maintained for longer than 10 minutes. A small number of patients, in the initial phase, rested a number of times, with gradual extension of each session duration, shortening the time and number of rest periods. |
|
| Outcomes |
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Random number digital table |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
Zhu 2011.
| Methods |
Design
|
|
| Participants |
Setting
Participants
Inclusion criteria
Exclusion criteria
|
|
| Interventions |
AMBMT The HQG group received daily morning training on “The Art of Expiration in Producing Six Different Sounds”, or Liuzijue (六字訣). A set was repeated 2 to 3 times per day for 3 months. PR Morning walk sessions on a flat uniform surface. Walking speed was maintained at 80 to 120 steps/min, for a cumulative walking duration of at least 45 minutes. Patients were allowed to take resting periods that would be progressively reduced in duration during the programme. |
|
| Outcomes |
Time points measured
|
|
| Notes |
Funding source
|
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Information about the sequence generation process insufficient to permit judgement of ‘low risk’ or ‘high risk’ |
| Allocation concealment (selection bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants were not blinded to the interventions |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Selective reporting (reporting bias) | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
| Other bias | Unclear risk | Information insufficient to permit judgement of 'low risk' or 'high risk' |
6MWD: six‐minute walk distance; 6MWT: six‐minute walk test; AECOPD: acute exacerbation of COPD; AMBMT: active mind‐body movement therapy; ATS: American Thoracic Society; BMI: body mass index; BODE: body‐mass index, airflow obstruction, dyspnoea, and exercise multi‐dimensional scoring system; BRTCQ: breathing regulating tai chi qigong; CAT: COPD Assessment Test; CCRQ: Chinese Chronic Respiratory Questionnaire; COPD: chronic obstructive pulmonary disease; COPD‐CSES: COPD Self‐efficacy Scale; CRQ: Chronic Respiratory Questionnaire; CTP: conventional training programme; DVD: digital optical disk; EQ‐5D: EuroQol group measure of health‐related quality of life; FEV₁: forced expiratory volume in one second; FVC: forced vital capacity; GOLD: Global Initiative for Chronic Obstructive Lung Disease; HQG: health qigong; HY: hatha yoga; IL: interleukin; ITT: intention‐to‐treat; MFTE: monitored functional task evaluation; mMRC: modified Medical Research Council Dyspnoea Scale; MRC: Medical Research Council; MSPSS‐C: Multi‐dimensional Scale of Perceived Social Support ‐ Chinese version; MVV: maximal voluntary ventilation; PaCO₂: partial pressure of carbon dioxide; PaO₂: partial pressure of oxygen; PR: pulmonary rehabilitation; QG: qigong; QoL: quality of life; QMVC: quadriceps maximum voluntary contraction; RCT: randomised controlled trial; SaO₂: oxygen saturation; SEMSOB: Stanford Self‐efficacy for Managing Shortness of Breath; SF‐36: Short Form Health Survey; SGRQ: St. George's Respiratory Questionnaire; TC: tai chai; TCM: Traditional Chinese Medicine; TCQ: tai chi qigong; TJQ: Taijiquan; TNF: tumour necrosis factor; TQG: tai chi with qigong.
Characteristics of excluded studies [ordered by study ID]
| Study | Reason for exclusion |
|---|---|
| Chen 2015 | No PR comparator |
| Cheng 2000 | Not an RCT |
| Cheng 2015 | No PR comparator |
| Deng 2016 | No PR comparator |
| Donesky‐Cuenco 2009 | No PR comparator |
| Dongxing 2011 | No PR comparator |
| Fukuoka 2016 | No proper AMBMT |
| Gao 2016 | No PR comparator |
| Guo 2013 | No PR comparator |
| Li 2012 | No PR comparator |
| Li 2015 | No PR comparator |
| Li 2016 | No PR comparator |
| Liang 2016 | No PR comparator |
| Liu 2013 | No PR comparator |
| Ma 2000 | No PR comparator |
| Ma 2009 | No PR comparator |
| Ni 2017 | No PR comparator |
| Shi 2011 | No PR comparator |
| Tan 2016 | No PR comparator |
| Tsang 2003 | Not COPD |
| Wang 2015 | No PR comparator |
| Wei 2015 | No PR comparator |
| Xu 2010 | No PR comparator |
| Xue 2015 | No PR comparator |
| Yao 2004 | No PR comparator |
| Yuan 2012 | No PR comparator |
| Zhang 2006 | No PR comparator |
| Zhang 2012 | No PR comparator |
| Zhang 2014 | No PR comparator |
| Zhang 2016c | No PR comparator |
| Zhang 2016d | Not an RCT (Review) |
| Zhou 2009 | No PR comparator |
| Zhu 2012 | No PR comparator |
| Zhu 2016 | No PR comparator |
AMBMT: active mind‐body movement therapy; COPD: chronic obstructive pulmonary disease; PR: pulmonary rehabilitation; RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study ID]
Cao 2016.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Gao 2017.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Kaminsky 2011.
| Methods | |
| Participants | |
| Interventions | |
| Outcomes | No outcome data published; contacted study author; no data will be published in the future |
| Notes |
Polkey 2018.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Price 2006.
| Methods | |
| Participants | |
| Interventions | |
| Outcomes | No outcome data published; contacted study author and received no response |
| Notes |
Ren 2017.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Singh 2016.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Xiao 2015.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Zhang 2016a.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Zhang 2016b.
| Methods | Not yet assessed |
| Participants | Not yet assessed |
| Interventions | Not yet assessed |
| Outcomes | Not yet assessed |
| Notes | Not yet assessed |
Characteristics of ongoing studies [ordered by study ID]
ChiCTR‐IOR‐17012437.
| Trial name or title | Effects of Shaolin‐Exercise on Pulmonary Rehabilitation for Elderly Patients With Stable COPD |
| Methods | Randomised parallel controlled trial |
| Participants |
Countries of recruitment and research settings Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University Inclusion criteria • Male or female aged 60 to 75 years old • Stable stage of chronic obstructive pulmonary disease under regular treatment with some symptoms • Obstructive ventilation dysfunction of any severity • Willingness to participate in the programme actively Exclusion criteria • Refusal to sign the informed consent form • Communication barriers • Other pulmonary diseases, such as pneumonia, and AECOPD ruled out • Determination by a doctor that individual cannot complete the programme or 6MWT safely • Unstable factors that impeded implementation of rehabilitation, like instability of complications, serious life‐threatening primary disease and mental disease • Already doing pulmonary rehabilitation exercise |
| Interventions |
AMBMT Shaolin exercise (SE) PR Western exercise |
| Outcomes |
|
| Starting date | 2017‐08‐21 to 2019‐12‐31 |
| Contact information | Jinxiu Lin; mayjinxiu@outlook.com |
| Notes |
ChiCTR‐TRC‐14004404.
| Trial name or title | A Randomized Controlled Trial of Health Qigong for Chronic Obstructive Pulmonary Disease Rehabilitation |
| Methods | Random parallel controlled trial |
| Participants |
Inclusion criteria • Stable chronic obstructive pulmonary disease • GOLD stage 1 to 4 Exclusion criteria • Acute myocardial ischaemia • Unstable angina • Severe stenosis or regurgitation • Congenital heart disease • Decompensated heart failure • Uncontrollable arrhythmia • Unstable hypertension or systolic blood pressure ≥ 180 mmHg • Diabetes with serious complications • Post stroke • Rheumatoid or rheumatoid arthritis or musculoskeletal disease or physical disability that seriously affects normal physical activity |
| Interventions |
AMBMT Health qigong group PR Routine exercise rehabilitation |
| Outcomes |
|
| Starting date | 2014 |
| Contact information | Chen Xianhai; Chenxianhai18@163.com |
| Notes |
NCT01998724.
| Trial name or title | Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial (LEAP) |
| Methods | The main purpose of this study is to determine the feasibility and effects of a 6‐month tai chi exercise programme as compared to a 6‐month group walking programme and standard care for patients with COPD who have recently completed a pulmonary rehabilitation programme |
| Participants |
Inclusion criteria • COPD defined as FEV₁ (forced expiratory volume in 1 second)/FVC (forced vital capacity) < 0.70 • Chest CT evidence of emphysema • Age > 40 years • COPD of any severity as defined by GOLD (Global Obstructive Lung Disease) stage 1, 2, 3, or 4 • Completion of standard pulmonary rehabilitation of at least 8 weeks' duration within 24 weeks before study entry* *Defined as attending 65% of programme sessions with a minimum of 10 sessions Exclusion criteria • COPD exacerbation requiring steroids, antibiotics, ED visit, or hospitalisation within the past 2 weeks unless physician deems patient at baseline • Hypoxaemia on walk test (O₂ sat < 85% on oxygen) • Inability to ambulate due to vascular or other neuromuscular conditions that would preclude a walk test • Clinical signs of unstable cardiovascular disease (i.e. chest pain on walk test) • Severe cognitive dysfunction (documented Mini Mental Status Exam ≤ 24) • Non‐English‐speaking • Current regular practice of tai chi • Current diagnosis of lung cancer or treatment for lung cancer within the past 5 years • Unstable/untreated mental health issue that precludes informed consent or otherwise affects ability to participate in the intervention |
| Interventions |
AMBMT Tai chi 24‐Week tai chi intervention designed for individuals with COPD PR Group walking exercise 24‐Week group walking intervention |
| Outcomes |
|
| Starting date | August 2012 to June 2018 |
| Contact information | Gloria Y. Yeh; gloria_yeh@hms.harvard.edu |
| Notes |
NCT02370654.
| Trial name or title | Chen‐style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease |
| Methods | This study will evaluate the effects of Chen‐style tai chi compared to conventional exercise in pulmonary rehabilitation for patients with COPD. Half of participants will receive the Chen‐style tai chi intervention, and the other half will receive the conventional exercise intervention. Both groups will receive the same eduction and support during pulmonary rehabilitation |
| Participants |
Inclusion criteria
Exclusion criteria
|
| Interventions |
AMBMT Tai chi 12‐Week tai chi intervention, 3 sessions per week, 90 minutes per session PR 12‐Week conventional exercise intervention, 3 sessions per week, 90 minutes per session |
| Outcomes |
|
| Starting date | March 2014 |
| Contact information | Louis Gendron; louis.gendron@criucpq.ulaval.ca |
| Notes |
6MWT: 6‐minute walk time; AECOPD: acute exacerbation of COPD; CAT: COPD Assessment Test; COPD: chronic obstructive pulmonary disease; CRQ: Chronic Respiratory Questionnaire; CT: computed tomography; ED: emergency department; FEV₁: forced expiratory volume in one second; FVC: forced vital capacity; GOLD: Global Initiative on Obstructive Lung Disease; mMRC: modified Medical Research Council Questionnaire; SE: Shaolin exercise; SF‐36: Short Form‐36 Questionnaire; SGRQ: St. George's Respiratory Questionnaire; SpO₂: peripheral capillary oxygen saturation; TCM: Traditional Chinese Medicine.
Differences between protocol and review
Regarding the Measures of treatment effect, the original protocol stated that when the standard deviation (SD) of the change was missing from a study, the mean value for the SD of other studies reporting that outcome was supposed to be used. Most included studies did not report the SD of change; therefore, we used instead the SD from the post‐intervention time point selected for analysis.
We included in this review the domain 'Risk of bias for performance bias'.
Contributions of authors
LMcG and AN contributed equally to this work.
LMcG co‐ordinated the review; designed search strategies; undertook searches and extraction and entry of data into RevMan; and contributed to data analysis and interpretation.
AN designed search strategies; undertook searches and extraction and entry of data into RevMan; and contributed to data analysis and interpretation.
DS contributed to interpretation of data and provided a clinical perspective and general advice on the review.
FM contributed to interpretation of data and provided a clinical perspective and general advice on the review.
YL provided a methodological perspective, a clinical perspective, and general advice on the review; and contributed to interpretation of data.
All review authors contributed to reading, writing, and approval of this review.
The review will be updated by LMcG and AN.
Sources of support
Internal sources
The review authors declare that no such funding was received for this systematic review, Other.
External sources
The review authors declare that no such funding was received for this systematic review, Other.
Declarations of interest
LMcG: none known.
AN: none known.
DS: none known.
Francois Maltais: grants for investigator‐initiated research from Boehringer Ingelheim; grants for contract research paid to his institution from Novartis, Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline; speaker honoraria paid to his group of respirologists from Boehringer Ingelheim and Novartis; consultancy fees from Boehringer Ingelheim; and position as CIHR/GlaxoSmithKline research chair on COPD.
YL: none known.
These authors contributed equally to this work
These authors contributed equally to this work
New
References
References to studies included in this review
Chan 2010 {published data only}
- Chan AWK, Lee A, Lee DTF, Sit JWH, Chair SY. Evaluation of the sustaining effects of tai chi qigong in the sixth month in promoting psychosocial health in COPD patients: a single‐blind, randomized controlled trial. Scientific World Journal 2013;425082:11 pages. [DOI: 10.1155/2013/425082] [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan AWK, Lee A, Lee DTF, Suen LKP, Tam WWS, Chair SY, et al. The sustaining effects of Tai Chi Qigong on physiological health for COPD patients: a randomized controlled trial. Complementary Therapies in Medicine 2013;21(6):585‐94. [DOI] [PubMed] [Google Scholar]
- Chan AWK, Lee A, Suen LKP, Tam WWS. Effectiveness of a Tai chi Qigong program in promoting health‐related quality of life and perceived social support in chronic obstructive pulmonary disease clients. Quality of Life Research 2010;19:653‐64. [DOI] [PubMed] [Google Scholar]
- Chan AWK, Lee A, Suen LKP, Tam WWS. Tai chi Qigong improves lung functions and activity tolerance in COPD clients: a single blind, randomized controlled trial. Complementary Therapies in Medicine 2011;19:3‐11. [DOI] [PubMed] [Google Scholar]
- Chan WK. Evaluation of a Tai Chi Qigong program in promoting physiological and psychosocial health statuses in chronic obstructive pulmonary disease clients. phdtree.org/pdf/25959404‐evaluation‐of‐a‐tai‐chi‐qigong‐program‐in‐promoting‐physiological‐and‐psychosocial‐health‐statuses‐in‐chronic‐obstructive‐pulmonary‐disease‐c/ (accessed 27 May 2016).
Du 2013 {published data only}
- Du ST, Ding LM, Wang CX, Yang FB, Xing B, Liu ZL, et al. The effect of Tai Chi Chuan on the exercise tolerance and lung function among COPD patients [太极拳运动对慢性阻塞性肺疾病患者运动耐力及肺功能的影响]. Chinese Journal of Rehabilitation Medicine 2013;28(4):374‐6. [Google Scholar]
- Du ST, Ding LM, Yang FB, Xing B, Wu JJ, Zhang J, et al. The effects of Taijiquan on serum concentration of interleukin‐6, interleukin‐8, tumor necrosis factor‐a in patients with chronic obstructive pulmonary disease in stationary stage [太极拳运动对稳定期慢性阻塞性肺疾病患者血清中IL‐6, IL‐8及TNF‐a含量的影响]. Chinese Journal of Physical Medicine and Rehabilitation 2014a;36(5):337‐40. [Google Scholar]
- Du ST, Xing B, He SL. Effects of Tai Chi on blood gas analysis in people with stable chronic obstructive pulmonary disease (translated from original title) [太极拳运动对稳定期慢性阻塞性肺疾病患者血气分析的影响]. Shanxi Medical Journal 2014b;43(1):79‐81. [Google Scholar]
- Du ST, Xing B, Wang CX, Ding LM, Yang FB, Liu CL, et al. The effects of Taijiquan practice on the BODE and SGRQ of COPD patients [太极拳运动对慢性阻塞性肺疾病患者BODE指数和SGRQ评分的影响]. Chinese Journal of Sports Medicine 2013;32(5):403‐8. [Google Scholar]
- Xing B, Ding LM, Wang CX, Yang FB, Liu CL, Zhu L. Translated title: Effect of Taiji quan on lung function in patients with COPD. [太极拳运动对慢性阻塞性肺疾病患者肺功能的影响]. Chinese Journal of Gerontology 2014;14:4046. [Google Scholar]
Liu 2012 {published data only}
- Liu XD, Jin HZ, Ng BHP, Gu YH, Wu YC, Lu G. Therapeutic effects of qigong in patients with COPD: a randomized controlled trial. Hong Kong Journal of Occupational Therapy 2012;22(1):38‐46. [Google Scholar]
Ng 2011 {published data only}
- Ng BHP, Tsang HWH, Jones AYM, So CT, Mok TYW. Functional and psychosocial effects of health qigong in patients with COPD: a randomized controlled trial. Journal of Alternative and Complementary Medicine 2011;17(3):243‐51. [DOI] [PubMed] [Google Scholar]
Ng 2014 {published data only}
- Ng L, Chiang LK, Tang R, Siu C, Fung L, Lee A, et al. Effectiveness of incorporating Tai Chi in a pulmonary rehabilitation program for Chronic Obstructive Pulmonary Disease (COPD) in primary care: a pilot randomized controlled trial. European Journal of Integrative Medicine 2014;6(3):248‐58. [Google Scholar]
Niu 2014 {published data only}
- Niu R, He R, Luo BL, Hu C. The effect of tai chi on chronic obstructive pulmonary disease: a pilot randomised study of lung function, exercise capacity and diaphragm strength. Heart, Lung and Circulation 2014;23(4):347‐52. [DOI] [PubMed] [Google Scholar]
Papp 2017 {published data only}
- Papp ME, Lindfors P, Wandell PE, Nygren‐Bonnier M. Effects of yogic exercises on functional capacity, lung function and quality of life in participants with obstructive pulmonary disease: a randomized controlled study. European Journal of Physical and Rehabilitation Medicine 2017;53(3):447‐61. [DOI] [PubMed] [Google Scholar]
Yang 2009 {published data only}
- Yang C. [中医综合肺康复治疗稳定期慢性阻塞性肺疾病的临床应用]. Clinical application of comprehensive pulmonary rehabilitation therapy for chronic obstructive pulmonary disease at stable stage [Masters thesis]. Guangzhou (China): Guangzhou University of Chinese Medicine, 2009. [Google Scholar]
Zhu 2010 {published data only}
- Zhu Y, Li N, Jin HZ. Effect on chronic obstructive pulmonary disease patient in stable condition by health qigong ‐ wuqinxi exercise early treatment [五禽戏早期干预对稳定期慢性阻塞性肺疾病患者的影响]. Journal of Liaoning University of Traditional Chinese Medicine 2010;12(6):107‐10. [Google Scholar]
Zhu 2011 {published data only}
- Zhen Z. The effect of health Qigong on the 61 stabilized patients with chronic obstructive pulmonary disease [健身气功对COPD稳定期6 1例呼吸功能的影响]. Journal of Nanjing TCM University 2011;27(3):235‐37. [Google Scholar]
References to studies excluded from this review
Chen 2015 {published data only}
- Chen YF, Liu S, Li R, Zhang X, Zhou L, Yang GF, Chen Y. Effect of Health Qigong Baduanjin on the Pulmonary Function of Patients with Chronic Obstructive Pulmonary Disease in Stable Period [对慢性阻塞性肺疾病稳定期患者肺功能的影响]. Chinese Medicine Modern Distance Education of China 2015;13(17):16‐18. [Google Scholar]
Cheng 2000 {published data only}
- Cheng K. Qigong and diet therapy combined, 23 cases of chronic bronchitis [气功合饮食疗法治疗慢性支气管炎23例]. Qigong Journal 2000;21(08):378‐9. [Google Scholar]
Cheng 2015 {published data only}
- Cheng Y‐F, Wei S‐S, He R. Clinical observation on the effect of traditional huatuo wuqin opera on stable stage of chronic obstructive pulmonary disease [传统华佗五禽戏对慢性阻塞性肺疾病稳定期患者临床疗效观察]. Clinical Journal of Traditional Chinese Medicine 2015;27(05):683‐5. [Google Scholar]
Deng 2016 {published data only}
- Deng ZX, Chen H, Xu ZB, et al. The effects of TaiChiquan on pulmonary rehabilitation for patients with stable chronic obstructive pulmonary disease [太极拳在稳定期慢性阻塞性肺疾病肺康复中的作用]. Journal of Anhui Health Vocational and Technical College 2016;15(2):18‐9. [Google Scholar]
Donesky‐Cuenco 2009 {published data only}
- Donesky‐Cuenco D, Nguyen HQ, Paul S, Carrieri‐Kohlman V. Yoga therapy decreases dyspnea‐related distress and improves functional performance in people with chronic obstructive pulmonary disease: a pilot study. Journal of Alternative and Complementary Medicine 2009;15(3):225‐34. [DOI] [PMC free article] [PubMed] [Google Scholar]
Dongxing 2011 {published data only}
- Dongxin Z. [改良运动处方对老年 COPD 稳定期患者的康复疗效]. Modified rehabilitation program for elderly patients with stable COPD [Masters thesis]. Guangzhou (China): Guangzhou Medical College, 2011. [Google Scholar]
Fukuoka 2016 {published data only}
- Fukuoka A, Ueda M, Ariyama Y, Iwai K, Kai Y, Kunimatsu M, et al. Effect of laughter yoga on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Journal of Nara Medical Association 2016;67:11‐20. [Google Scholar]
Gao 2016 {published data only}
- Gao W. Health Qigong Yijinjing promotes pulmonary rehabilitation in patients with stable COPD [健身气功易筋经促进COPD稳定期患者肺康复的研究]. Journal of Chengde Medical College 2016;33(4):307‐9. [Google Scholar]
Guo 2013 {published data only}
- Guo HX, Qiu ZH, Zhong NS, Polkey MI, Luo YM. Physiological responses to Tai Chi in stable patients with COPD [Abstract]. European Respiratory Journal 2013;42(Suppl 57). [DOI] [PubMed] [Google Scholar]
Li 2012 {published data only}
- LI Q, Fanf W, Liu C. The effect of taijiquan combined with respiratory exercise training on rehabilitation of patients with stable chronic obstructive pulmonary disease [太极拳联合呼吸功能训练对稳定期慢性 阻塞性肺疾病患者康复的影响]. Chinese Journal of Rehabilitation Medicine 2012;27(9):825‐8. [Google Scholar]
Li 2015 {published data only}
- Li R‐F, Wang Y‐H, Songyan W. Effects of Pilates breathing and breathing training on lung function and quality of life in elderly patients with chronic obstructive pulmonary disease [普拉提式呼吸和呼吸训练对老年COPD患者的肺功能改善及生活质量的影响]. Chinese and Foreign Medical Research 2015;13(17):118‐20. [Google Scholar]
Li 2016 {published data only}
- Li S, Li A, Sun W, Wang H. Effects of Tai Chi Quan rehabilitation in patients with chronic obstructive pulmonary disease [太极拳康复对慢性阻塞性肺疾病患者的影响]. Journal of Binzhou Medical College 2016;39(4):275‐8. [Google Scholar]
Liang 2016 {published data only}
- Liang X. Ba Duan Jin single‐lift rehabilitation exercise for the rehabilitation of patients with chronic obstructive pulmonary disease [八段锦单举式康复锻炼对慢性阻塞性肺疾病患者康复的影响]. Nursing Practice and Research 2016;13(17):156‐7. [Google Scholar]
Liu 2013 {published data only}
- Liu S, Chen Y‐F. Clinical study on the effect of Health Qigong Ba Duan Jin on patients with chronic obstructive pulmonary disease at stable stage [健身气功八段锦对慢性阻塞性肺病稳定期患者影响的临床研究]. Sichuan Medicine 2014;35(11):1481‐2. [Google Scholar]
- Liu S, Chen Y‐F. Clinical study on the effect of health Qigong Ba Duan Jin on improving the walking distance of patients with chronic obstructive pulmonary disease [健身气功八段锦对慢性阻塞性肺疾病稳定期患者6min步行距离改善的临床研究]. Sichuan Medical Journal 2013;34(8):1090‐2. [Google Scholar]
- Liu S, Chen Y‐F. Short term curative effects of Fitness Qigong and Baduanjin on pulmonary function in stable COPD patients [健身气功八段锦对慢性阻塞性肺疾病稳定期患者肺功能近期疗效观察]. West China Medical Journal 2012;27(8):1248‐50. [Google Scholar]
Ma 2000 {published data only}
- Ma Y, Wu J, Yuan W, Cheng A. Rehabilitation of patients with mild COPD by aerobic training, abdominal breathing and qigong [有氧训练、腹式呼吸和气功对轻度COPD患者的康复作用]. Modern Rehabilitation 2000;4(05):708‐9. [Google Scholar]
Ma 2009 {published data only}
- Ma W‐H, Wang H‐L, Lin X‐Z, Zhu Y‐C, Zhang H‐Y, Nan G‐Y. Investigation on compliance of respiratory exercise in patients with COPD and nursing intervention [COPD患者呼吸锻炼依从性的调查研究及护理干预]. Journal of Clinical Pulmonary Medicine 2009;14(6):850. [Google Scholar]
Ni 2017 {published data only}
- Ni K. Therapeutic effect of yoga and Taiji on COPD remission [瑜伽、太极对COPD 缓解期的疗效观察]. World Latest Medicine Information 2017;17(92):182‐3. [Google Scholar]
Shi 2011 {published data only}
- Shi D. Effect of exercise health care on airway inflammatory response in patients with chronic obstructive pulmonary disease [运动保健护理对慢性阻塞性肺疾患者气道炎性反应的影响]. Chinese Journal of Medical Guide 2011;9(09):142‐4. [Google Scholar]
Tan 2016 {published data only}
- Tan PH, Liu FY, Zhang JH, Peng XQ, Tang T, Yang YL. Wu Qin Xi on the quality of life of patients with stable chronic obstructive pulmonary disease [五禽戏对慢性阻塞性肺疾病稳定期病人生活质量观察研究]. Lingnan Journal of Emergency Medicine 2016;21(6):629‐30. [Google Scholar]
Tsang 2003 {published data only}
- Tsang HW, Mok CK, Au Yeung YT, Chan SY. The effect of Qigong on general and psychosocial health of elderly with chronic physical illnesses: a randomized clinical trial. International Journal of Geriatric Psychiatry 2003;18(5):441‐9. [DOI] [PubMed] [Google Scholar]
Wang 2015 {published data only}
- Wang J‐Y. Clinical observation of herbal administration and eight‐section brocade in treating chronic obstructive pulmonary disease of stable stage [中药内服联合八段锦功法治疗稳定期慢性阻塞性肺疾病临床观察]. Shanghai Journal of Traditional Chinese Medicine 2015;49(7):41‐65. [Google Scholar]
Wei 2015 {published data only}
- Wei S‐S, Cheng Y‐F, He R. Effect of traditional Huatuo Wuqinxi on lung function in patients with stable chronic obstructive pulmonary disease [传统华佗五禽戏对慢性阻塞性肺疾病稳定期患者肺功能的影响]. Clinical Journal of Traditional Chinese Medicine 2015;27(06):793‐5. [Google Scholar]
Xu 2010 {published data only}
- Xu YH, Deng Y, He X. Effect of qigong combined with respiratory rehabilitation training on lung function and exercise endurance in patients with chronic obstructive pulmonary disease [气功结合呼吸康复训练对慢性阻塞性肺疾病患者肺功能及运动耐力的影响]. Journal of Practical Medicine 2010;26(12):2139‐41. [Google Scholar]
- Xu YH, Wang J, Deng Y, He X. Effect of Chinese and Western combination of respiratory rehabilitation training on exercise capacity in patients with chronic obstructive pulmonary disease [中西结合呼吸康复训练对慢性阻塞性肺疾病患者运动能力的影响]. Chinese Journal of Clinical Healthcare 2010;13(03):263‐5. [Google Scholar]
- Xu YH, Wang JH, Li HF, Zhu XH, Wang G. Efficacy of integrative respiratory rehabilitation training in exercise ability and quality of life of patients with chronic obstructive pulmonary disease in stable phase: a randomized controlled trial [中西医结合康复训练对慢性阻塞性肺疾病患者运动能力及生活质量的影响:随机对照临床试验]. Journal of Chinese Integrative Medicine 2010;8(5):432‐7. [DOI: 10.3736/jcim20100506] [DOI] [PubMed] [Google Scholar]
Xue 2015 {published data only}
- Xue GW,Feng CL,Yao XQ,Qi Y,Wang YN,Ma J. Efficacy of fitness qigong Ba Duan Jin in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease at stable stage [健身气功八段锦在慢性阻塞性肺疾病稳定期肺康复中的疗效评价]. Journal of Beijing University of Traditional Chinese Medicine 2015;38(2):139‐44. [Google Scholar]
Yao 2004 {published data only}
- Yao YP. Effect of Tai Chi Chuan on chronic obstructive pulmonary disease [太极拳对慢性阻塞性肺疾病康复疗效观察]. Chinese Journal of Rehabilitation Theory and Practice 2004;10(7):439‐40. [Google Scholar]
Yuan 2012 {published data only}
- Yuan J‐H, Li Y‐N, Liang Y‐L. The effect of "Taijiquan" on pulmonary function in COPD patients during rehabilitation [水中太极拳对COPD康复期患者肺通气的影响及疗效观察]. Seventh Session of the Beijing International Rehabilitation Forum papers. 2012.
Zhang 2006 {published data only}
- Zhang W, Chen W‐H, Jin W, Wu W. Formulation and application of exercise prescription for TCM in chronic obstructive pulmonary disease [慢性阻塞性肺病中医养生锻炼运动处方的制定和应用]. 8th National Conference on Physical Medicine and Rehabilitation, Chinese Medical Association. 2006‐09:1.
Zhang 2012 {published data only}
- Zhang LH, Wu JJ, Wang ZC. Effects of 24‐form tai chi with respiratory rehabilitation training on pulmonary function and quality of life of patients with COPD [二十四式太极拳结合呼吸康复训练对COPD患者肺功能及生活质量的影响]. Acta Universitatis Traditionis Medicalis Sinensis Pharmacologiaeque Shanghai 2012;26(4):53‐6. [Google Scholar]
Zhang 2014 {published data only}
- Zhang XC, Cai YL, Zhang W, Chen XH, Jia XH, Zhang XY, et al. Effect of 24‐style Tai Chi combined with respiratory function training and western medicine on stable COPD [二十四式太极拳及呼吸功能训练辅助西药对慢性阻塞性肺疾病稳定期患者的影响]. Journal of Traditional Chinese Medicine / Chung i Tsa Chih Ying Wen Pan 2014;55(22):1937‐41. [Google Scholar]
Zhang 2016c {published data only}
- Zhang M, Xu G, Li F, Luo C, Meng D, Ji Y. Chinese gymnastic Qigong‐Yijinjing promotes the function of patients with chronic obstructive pulmonary disease [健身气功易筋经促进慢性阻塞性肺疾病稳定期患者康复]. Chinese Journal of Sports Medicine 2016;35(4):339‐43. [Google Scholar]
Zhang 2016d {published data only}
- Zhang Y. Study of Tai chi and fitness Qigong promote recovery of lung function in patients with COPD [太极拳与健身气功促进COPD 患者肺功能恢复研究进展]. Journal of Shangqiu Normal University 2016;32(3):86‐8. [Google Scholar]
Zhou 2009 {published data only}
- Zhou Y, Wu L, Wang DX. The rehabilitative effects of Taijiquan training with east medical on middle‐elderly COPD patients [太极拳锻炼配合中医疗法对中老年COPD患者的康复影响]. Journal of Kilin Institute of Physical Education 2009;25(6):54‐5. [Google Scholar]
Zhu 2012 {published data only}
- Zhu Z, Zhang S‐Q. Effect of health Qigong rehabilitation on respiratory function and quality of life of patients with stable stage of chronic obstructive pulmonary disease [健身气功肺康复法对慢性阻塞性肺疾病稳定期患者呼吸功能及生存质量的影响]. Chinese Archives of Traditional Chinese Medicine 2012;32(8):803‐4. [Google Scholar]
Zhu 2016 {published data only}
- Zhu Z, Chen Y. Sitting‐style Ba Duan Jin exercise on activity endurance and quality of life in patients with chronic obstructive pulmonary disease [坐式八段锦锻炼对慢性阻塞性肺疾病患者活动耐力和生活质量的影响]. Chinese Journal of Gerontology 2016;36(9):2265‐6. [Google Scholar]
References to studies awaiting assessment
Cao 2016 {published data only}
- Cao C, Guo X, Chen N, Yan X, Zhang H. Research of effects of eight‐section brocade of TCM on treating anxiety and depression in the elderly patients with lung‐spleen Qi deficiency in stable period of COPD [八段锦对改善COPD稳定期肺脾气虚证社区老年患者焦虑、抑郁效果研究]. Journal of Liaoning University of TCM 2016;18(8):120‐3. [Google Scholar]
Gao 2017 {published data only}
- Gao Y, Yan Y, Chen M. Wu Qin Xi exercise on lung function and exercise tolerance in patients with chronic obstructive pulmonary disease during transitional transition [五禽戏锻炼对出院过渡期慢性阻塞性肺疾病患者肺功能及运动耐量的影响]. Journal of Clinical and Pathological Research 2017;37(5):975‐80. [Google Scholar]
Kaminsky 2011 {published data only}
- Kaminsky D, Knyazhitskiy A, Stevens D, Hunton D. Feasibility of adding Tai Chi Chuan to a pulmonary rehabilitation program involving a Western population of patients [Abstract]. Respirology 2011;16(Suppl 2):6 [532]. [Google Scholar]
Polkey 2018 {published data only}
- Polkey MI, Qiu ZH, Zhou L, Zhu MD, Wu YX, Chen YY, et al. Tai chi and pulmonary rehabilitation compared for treatment‐naive patients with COPD: a randomized controlled trial. Chest 2018;153(5):1116‐24. [DOI] [PubMed] [Google Scholar]
Price 2006 {published data only}
- Price A, Meah M, O'Shaughnessy T. A pilot study to compare qiqong exercises with conventional exercises in pulmonary rehabilitation [Abstract]. Thorax 2006;61(ii67 [P032]):Suppl 2. [Google Scholar]
Ren 2017 {published data only}
- Ren ZF, Zhang X, Hou GH, Yang B, Kang XH, Wang Z, et al. Effects of Tai Chi Zen on exercise ability and quality of life in chronic obstructive pulmonary disease [太极禅对慢性阻塞性肺疾病运动能力及生活质量的影响]. China Journal of Traditional Chinese Medicine and Pharmacy 2017;32(8):3507‐10. [Google Scholar]
Singh 2016 {published data only}
- Singh M, Srivastava GN, Meena M, Singh S. Adapting local practices can increase compliance and hence outcome of pulmonary rehabilitation (PR) in resource limited settings. European Respiratory Journal. Conference: European Respiratory Society Annual Congress 2016. United Kingdom 2016; Vol. 48.
Xiao 2015 {published data only}
- Xiao CM, Zhuang YC. Efficacy of Liuzijue Qigong in individuals with chronic obstructive pulmonary disease in remission. Journal of the American Geriatrics Society 2015;63(7):1420‐5. [DOI] [PubMed] [Google Scholar]
Zhang 2016a {published data only}
- Zhang M, Xv G, Luo C, Meng D, Ji Y. Qigong Yi Jinjing promotes pulmonary function, physical activity, quality of life and emotion regulation self‐efficacy in patients with chronic obstructive pulmonary disease: a pilot study. Journal of Alternative and Complementary Medicine 2016;22(10):8170‐7. [DOI] [PubMed] [Google Scholar]
Zhang 2016b {published data only}
- Zhang X, Chen PJ, Wei HG. Effect of aerobic exercise on cognitive function and emotion of patients with stable COPD [有氧运动对稳定期COPD患者认知功能及情绪的影响研究]. 4th National Conference on Sports Physiology and Biochemistry ‐ Compilation of Sports, Constitution, and Health Papers. Wuxi, Jiangsu Province, China, 2016.
References to ongoing studies
ChiCTR‐IOR‐17012437 {published data only}
- ChiCTR‐IOR‐17012437. Effects of Shaolin‐Exercise on Pulmonary Rehabilitation for Eldly Patients With Stable COPD [基于“少林内功”的呼吸康复训练对老年慢性阻塞性肺疾病稳定期疗效观察]. http://www.chictr.org.cn/showprojen.aspx?proj=21181 (first received 21 August 2017).
ChiCTR‐TRC‐14004404 {published data only}
- ChiCTR‐TRC‐14004404. A Randomized Controlled Trial of Health Qigong for Chronic Obstructive Pulmonary Disease Rehabilitation [健身气功对慢性阻塞性肺疾病康复作用的随机对照试验]. http://www.chictr.org.cn/hvshowproject.aspx?id=9520 (first received 25 August 2016).
NCT01998724 {published data only}
- NCT01998724. Tai Chi After Pulmonary Rehabilitation in Patients With COPD: A Randomized Trial. https://clinicaltrials.gov/ct2/show/NCT01998724 (first received 2 December 2013).
NCT02370654 {published data only}
- NCT02370654. Chen‐style Tai Chi in Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease. https://clinicaltrials.gov/ct2/show/NCT02370654 (first received 25 February 2015).
Additional references
Alma 2016
- Alma H, Jong C, Jelusic D, Wittmann M, Schuler M, Flokstra‐de Blok B, et al. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. Primary Care Respiratory Journal 2016;26:16041. [DOI: 10.1038/npipcrm.2016.41; PUBMED: 27597571] [DOI] [PMC free article] [PubMed] [Google Scholar]
Borge 2014
- Borge CR, Hagen KB, Mengshoel AM, Omenaas E, Moum T, Wahl AK. Effects of controlled breathing exercises and respiratory muscle training in people with chronic obstructive pulmonary disease: results from evaluating the quality of evidence in systematic reviews. BMC Pulmonary Medicine 2014;14(1):184. [DOI] [PMC free article] [PubMed] [Google Scholar]
Buist 2007
- Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): a population‐based prevalence study. Lancet 2007;370(9589):741‐50. [PUBMED: 17765523] [DOI] [PubMed] [Google Scholar]
Bullo 2015
- Bullo V, Bergamin M, Gobbo S, Sieverdes JC, Zaccaria M, Neunhaeuserer D, et al. The effects of Pilates exercise training on physical fitness and wellbeing in the elderly: a systematic review for future exercise prescription. Preventive Medicine 2015;75:1‐11. [DOI] [PubMed] [Google Scholar]
Butcher 2012
- Butcher SJ, Pikaluk BJ, Chura RL, Walkner MJ, Farthing JP, Marciniuk DD. Associations between isokinetic muscle strength, high‐level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:537‐42. [PUBMED: 22973094] [DOI] [PMC free article] [PubMed] [Google Scholar]
Cahalin 2002
- Cahalin LP, Braga M, Matsuo Y, Hernandez ED. Efficacy of diaphragmatic breathing in persons with chronic obstructive pulmonary disease: a review of the literature. Journal of Cardiopulmonary Rehabilitation 2002;22(1):7‐21. [PUBMED: 11839992] [DOI] [PubMed] [Google Scholar]
Cai 2004
- Cai YY, Li ZZ, Fang ZJ. Assessing quality of life in patients with chronic obstructive pulmonary disease [慢性阻塞性肺疾病患者生存质量评估]. Chinese Journal of General Practitioners 2004;3(4):225‐7. [Google Scholar]
Chen 2016
- Chen YW, Hunt MA, Campbell KL, Peill K, Reid WD. The effect of Tai Chi on four chronic conditions ‐ cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: a systematic review and meta‐analyses. British Journal of Sports Medicine 2016;50(7):397‐407. [PUBMED: 26383108] [DOI] [PubMed] [Google Scholar]
Cohen 2015
- Cohen JF, Korevaar DA, Wang J, Spijker R, Bossuyt PM. Should we search Chinese biomedical databases when performing systematic reviews?. Systematic Reviews 2015;4:23. [DOI] [PMC free article] [PubMed] [Google Scholar]
Desveaux 2015
- Desveaux L, Janaudis‐Ferreira T, Goldstein R, Brooks D. An international comparison of pulmonary rehabilitation: a systematic review. COPD 2015;12(2):144‐53. [PUBMED: 24984085] [DOI] [PubMed] [Google Scholar]
Ding 2014
- Ding M, Zhang W, Li K, Chen X. Effectiveness of t'ai chi and qigong on chronic obstructive pulmonary disease: a systematic review and meta‐analysis. Journal of Alternative and Complementary Medicine (New York, NY) 2014;20(2):79‐86. [PUBMED: 23961940] [DOI] [PMC free article] [PubMed] [Google Scholar]
Garvey 2016
- Garvey C, Bayles MP, Hamm LF, Hill K, Holland A, Limberg TM, et al. Prescription in chronic obstructive pulmonary disease: review of selected guidelines. Journal of Cardiopulmonary Rehabilitation and Prevention 2016;36:75‐83. [DOI] [PubMed] [Google Scholar]
GOLD 2018
- Global Initiative for Chronic Obstructive Lung Disease. From the global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. goldcopd.org/wp‐content/uploads/2017/11/GOLD‐2018‐v6.0‐FINAL‐revised‐20‐Nov_WMS.pdf (accessed prior to 20 March 2018 ‐ 4 July 2016). [PUBMED: 22878278] 22878278
GRADEpro GDT [Computer program]
- McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 14 July 2016. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Guo 2016
- Guo JB, Chen BL, Lu YM, Zhang WY, Zhu ZJ, Yang YJ, et al. Tai Chi for improving cardiopulmonary function and quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta‐analysis. Clinical Rehabilitation 2016;30(8):750‐64. [PUBMED: 26396162] [DOI] [PubMed] [Google Scholar]
Hagins 2007
- Hagins M, Moore W, Rundle A. Does practicing hatha yoga satisfy recommendations for intensity of physical activity which improves and maintains health and cardiovascular fitness?. BMC Complementary and Alternative Medicine 2007;7:40. [DOI] [PMC free article] [PubMed] [Google Scholar]
Harris 2012
- Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. International Journal of Clinical Practice 2012;66(10):924‐39. [DOI] [PubMed] [Google Scholar]
Higgins 2011
- Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Houchen 2009
- Houchen L, Steiner MC, Singh SJ. How sustainable is strength training in chronic obstructive pulmonary disease?. Physiotherapy 2009;95(1):1‐7. [PUBMED: 19627679] [DOI] [PubMed] [Google Scholar]
Jaeschke 1989
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials 1989;10(4):407‐15. [PUBMED: 2691207] [DOI] [PubMed] [Google Scholar]
Jahnke 2010
- Jahnke R, Larkey L, Rogers C, Etnier J, Lin F. A comprehensive review of health benefits of qigong and tai chi. American Journal of Health Promotion 2010;24(6):e1‐e25. [DOI] [PMC free article] [PubMed] [Google Scholar]
Jones 2005
- Jones PW. St. George's Respiratory Questionnaire: MCID. COPD 2005;2(1):75‐9. [DOI] [PubMed] [Google Scholar]
Lan 2008
- Lan C, Chen SY, Lai JS. The exercise intensity of Tai Chi Chuan. Medicine and Sport Science 2008;52:12‐9. [DOI] [PubMed] [Google Scholar]
Lee 2014
- Lee M, Kim T, Shin B, Ernst E. Mind‐body movement therapies for Parkinson's disease. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD011266] [DOI] [Google Scholar]
Maltais 2014
- Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2014;189(9):e15‐62. [PUBMED: 24787074] [DOI] [PMC free article] [PubMed] [Google Scholar]
McCarthy 2015
- McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003793.pub3] [DOI] [PMC free article] [PubMed] [Google Scholar]
Miravitlles 2007
- Miravitlles M, Molina J, Naberan K, Cots JM, Ros F, Llor C, et al. Factors determining the quality of life of patients with COPD in primary care. Therapeutic Advances in Respiratory Disease 2007;1(2):85‐92. [DOI] [PubMed] [Google Scholar]
Moher 2009
- Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097] [DOI] [PMC free article] [PubMed] [Google Scholar]
Ng 2014a
- Ng BH, Tsang HW, Ng BF, So CT. Traditional Chinese exercises for pulmonary rehabilitation: evidence from a systematic review. Journal of Cardiopulmonary Rehabilitation and Prevention 2014;34(6):1‐11. [DOI] [PubMed] [Google Scholar]
Ngai 2016
- Ngai SPC, Jones AYM, Tam WWS. Tai Chi for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2016, Issue 6. [DOI: 10.1002/14651858.CD009953.pub2] [DOI] [PMC free article] [PubMed] [Google Scholar]
RevMan 2014 [Computer program]
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Santaella 2011
- Santaella DF, Devesa CRS, Rojo MR, Amato MBP, Drager LF, Casali KR, et al. Yoga respiratory training improves respiratory function and cardiac sympathovagal balance in elderly subjects: a randomised controlled trial. BMJ Open 2011;1:e000085. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schulz 2002
- Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002;359(9308):781‐5. [DOI] [PubMed] [Google Scholar]
Spruit 2013
- Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine 2013;188(8):e13‐64. [PUBMED: 24127811] [DOI] [PubMed] [Google Scholar]
Taneja 2014
- Taneja DK. Yoga and health. Indian Journal of Community Medicine 2014;39(2):68‐72. [DOI] [PMC free article] [PubMed] [Google Scholar]
Vogelmeier 2017
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2017;195(5):557‐82. [DOI] [PubMed] [Google Scholar]
WHO 2013
- World Health Organization. Chronic respiratory diseases ‐ burden of COPD. www.who.int/respiratory/copd/burden/en/ (accessed 8 October 2015).
Wu 2014
- Wu W, Liu X, Wang L, Wang Z, Hu J, Yan J. Effects of Tai Chi on exercise capacity and health‐related quality of life in patients with chronic obstructive pulmonary disease: a systematic review and meta‐analysis. International Journal of Chronic Obstructive Pulmonary Disease 2014;9:1253‐63. [PUBMED: 25404855] [DOI] [PMC free article] [PubMed] [Google Scholar]
Xia 2008
- Xia J, Wright J, Adams CE. Five large Chinese biomedical bibliographic databases: accessibility and coverage. Health Information and Libraries Journal 2008;1:55‐61. [DOI] [PubMed] [Google Scholar]
Yan 2013
- Yan JH, Guo YZ, Yao HM, Pan L. Effects of Tai Chi in patients with chronic obstructive pulmonary disease: preliminary evidence. PloS One 2013;8(4):e61806. [DOI] [PMC free article] [PubMed] [Google Scholar]
Yeh 2014
- Yeh GY, Wayne PM, Litrownik D, Roberts DH, Davis RB, Moy ML. Tai chi mind‐body exercise in patients with COPD: study protocol for a randomized controlled trial. Trials 2014;15:337. [DOI] [PMC free article] [PubMed] [Google Scholar]
References to other published versions of this review
Gendron 2016
- Gendron LMc, Nyberg A, Maltais F, Lacasse Y. Active mind‐body movement therapies as an adjunct to or in comparison to pulmonary rehabilitation for people with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2016, Issue 7. [DOI: 10.1002/14651858.CD012290] [DOI] [PMC free article] [PubMed] [Google Scholar]
